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ABSTRACT 
 
Coxiella burnetii, the causative agent of Q fever in humans, is a Gram-negative 
intracellular bacterium. Although the organism was first isolated in the 1930s, little is 
known about the specific mechanisms underlying its virulence. This is largely due to its 
obligate intracellular lifestyle. Recent advances in both axenic growth and genetic 
manipulation of C. burnetii allowed efficient generation and isolation of random 
mutations and enabled more definitive studies of the genes essential for virulence. The 
goal of this project was to generate a large collection of specific isogenic C. burnetii 
mutants and employ in vitro and in vivo screens to determine the individual contributions 
of their affected genes to pathogenicity. We used a Himar1 transposon system to 
generate a library of 1) defined clonal mutants and 2) pools of random transposon 
mutants in order to approach saturation with non-lethal mutants of the low virulence C. 
burnetii isolate, Nine Mile, phase II (NMII), RSA 439, which is approved for use in a 
biosafety level two laboratory. Mutants from both libraries were compared in various 
growth conditions or infection models to identify differences in growth phenotype 
relative to wild-type C. burnetii. The libraries are also amenable to high-throughput 
analysis using transposon sequencing or transposon directed insertion site sequencing 
(TraDIS) to compare pooled mutants between input and output infection assays.  
In this study, we optimized methods to generate defined transposon mutants, 
resulting in mutations in nearly 20% of the predicted open reading frames (ORFs) and 
provide methodology to expand the library for future studies. Included in these mutants 
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were a number of bioinformatically predicted virulence factors based on phenotypes in 
other bacterial pathogens that we further compared in cellular and animal models of 
infection. Our findings are consistent with previous studies that demonstrate the Dot/Icm 
T4BSS is essential for generating and replicating in a large parasitophorous vacuole 
(PV). We developed methods for high throughput screening of Tn mutants in vitro by 
imaging on either confocal microscope or BioTek Cytation3 imaging system. We 
generated a genome saturation transposon mutant pool by combining transposon mutant 
pools from 35 independent transformation reactions. These combined in vitro and in vivo 
screens dramatically improve our knowledge of specific virulence determinants for this 
pathogen and provide a substantial amount of data for future studies. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Background 
Coxiella burnetii is a Gram-negative, intracellular bacterium that causes acute 
and chronic Q fever in humans. It is highly infectious, requiring very few organisms to 
cause disease. Infection in most animals is asymptomatic but causes abortion and 
infertility in domestic animals including cattle, sheep, and goats [1]. Acute Q fever is a 
self-limiting illness in humans typically presenting as a flu-like syndrome, pneumonia, 
or granulomatous hepatitis with symptoms developing within a few days to a few weeks 
after exposure. The acute disease is effectively treated by antibiotics, which reduce the 
duration of symptoms and likelihood of chronic infection [2]. Still, many people never 
receive treatment because they do not show symptoms of the disease. While most 
patients recover from the acute infection, others can develop severe, chronic disease 
most often presenting as endocarditis. Chronic infection, which is fatal in some cases, 
may develop weeks or even years after the acute infection. The disease is distributed 
worldwide, with 100-200 cases reported annually in the United States [3]. 
Due to its non-specific disease presentation, C. burnetii infection can be difficult 
to distinguish from other diseases, making early detection a challenge. While antibiotic 
therapy is most effective if started within a few days of infection, antibodies cannot be 
detected until a week or two after infection. Physicians must therefore rely on clinical 
suspicion when diagnosing Q fever. This diagnosis can later be confirmed by an indirect 
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immunofluorescence assay (IFA), a serological test for reactivity of serum with fixed 
whole cell C. burnetii. Antibiotic treatment with doxycycline is most effective and 
should be started early, even before lab results confirm the disease [4]. 
C. burnetii can survive in extreme weather and environmental conditions for long 
periods of time and can resist many common disinfectants. Humans typically become 
infected by inhaling contaminated dust particles. Personnel working with livestock and 
in research laboratories are considered high risk as infection commonly occurs via the 
respiratory route following inhalation of infectious aerosols produced by these animals. 
Infection by ingestion and human-to-human transmission are possible, but rare [5].  
 Genome sequencing indicates the Coxiella genome ranges between ~2.0 – 2.2 
Mb and are organized as circular chromosomes normally associated with a single 
autonomous plasmid [6]. C. burnetii isolates were analyzed and differentiated into six 
distinct genomic groups (I to VI) based on DNA restriction fingerprints [7]. Human 
isolates within groups I, II, and III were derived from acute disease patients, while 
isolates in groups IV and V were from chronic disease patients. Isolates in group VI 
were isolated from rodents near Dugway, Utah [7]. Four plasmid types have been 
designated, termed QpH1, QpRS, QpDV, and QpDG [8,9]. These plasmids share a 
common 25-kb region. Strains that lack plasmids contain chromosomally integrated 
plasmid-like sequences (IPS), suggesting plasmid and IPS genes are important for 
infection [10].  
 Early studies showed a correlation between the plasmids and a distinct genomic 
group. However, since nucleotide sequences were determined for these plasmids [6] and 
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genotyping revealed crossover between plasmids with different groups [11], human 
disease may not be determined by plasmid type. However, because these sequences are 
maintained by all C. burnetii isolates, they are believed to be critical for survival [10]. 
Gene designations distinguish between chromosome and plasmid sequences. Three 
letters (CBU) followed by four numbers designate genes located on the chromosome, 
while four letters (CBUA) followed by four numbers designate genes on the plasmid. 
 The Coxiella strain used in this study was isolated from a tick in 1935 collected 
in Nine Mile Creek, Montana, and therefore designated the Nine Mile (NM) strain. A 
group studying Rocky Mountain spotted fever discovered this unknown agent about the 
same time the first outbreak of Q fever occurred in Australia [12]. A laboratory-acquired 
infection led to the determination that the Q fever and Nine Mile agents were the same 
pathogen [4]. The NM strain is in chromosomal group I and contains the cryptic QpH1 
plasmid. C. burnetii plasmids and IPS have been shown to encode Dot/Icm T4SS 
substrates, including three that are specific to QpH1 [10]. Generating mutants in these 
genes will be important in defining their roles in infection and virulence.  
 Unlike many other bacterial pathogens, C. burnetii requires a eukaryotic host 
vacuole for metabolism and replication. This presents a particularly unique problem for 
the host immune system, since the bacterium actually resides in macrophages, the cells 
responsible for killing invading pathogens [13]. C. burnetii lipopolysaccharide (LPS), 
studied for its potential role in virulence, undergoes phase variation in the laboratory 
setting from virulent or “phase I” (PI or NMI) to avirulent or “phase II” (PII or NMII). 
Virulent C. burnetii produces a full-length, smooth LPS with a complete O-antigen that 
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becomes truncated after serial passage in vitro. PII Coxiella have rough LPS, which 
lacks O-antigen sugars, and some LPS core components [5]. A second LPS variant of 
NMI, Nine Mile Crazy (NMC), has been described as producing intermediate-length 
LPS and having intermediate virulence [14]. As the O-antigen is the only known 
alteration between virulent and avirulent C. burnetii, PI-LPS is hypothesized to play a 
critical role in virulence. Comparisons of disease caused by PI and PII C. burnetii in 
SCID mice demonstrated that acquired immunity is essential to overcome both 
infections [15].  
 While there are control measures that can be taken to prevent the spread of Q 
fever, immunization is the most practical method for preventing the disease in both 
animals and at-risk humans. A PI inactivated whole cell vaccine, derived from the Nine 
Mile C. burnetii strain (Coxevac, CEVA, France) has proven effective for immunizing 
ruminants [16]. The only human vaccine currently in use is a formalin-inactivated C. 
burnetii PI whole cell vaccine, Q-VAX
®
, derived from the purified LPS of the 
Henzerling strain (Commonwealth Serum Laboratories, Parkville, Victoria, Australia), 
which is produced and licensed for use in Australia. Neither of these vaccines is 
approved for use in the United States [17]. 
  Though the protective efficacy of Q-VAX
®
 approaches 100%, this vaccine 
causes severe reactions in individuals who have previously been exposed to C. burnetii 
[18].  A number of individuals who have not previously had contact with the bacterium 
experience less severe, but still serious side effects. Therefore, this vaccine requires 
costly, time intensive, and unreliable prescreening prior to administration [19]. 
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Consequently, there is a need for a safe and effective subunit vaccine for human use 
against C. burnetii.  
 Understanding the mechanisms of protection induced by the PI vaccine would be 
valuable in developing a safe and effective new generation vaccine against Q fever. 
Components of Q-VAX
®
 that may allow it to be an effective vaccine include PI LPS or a 
component of it, proteins that stimulate the cell-mediated immune (CMI) response or 
antibody-mediated immune (AMI) response, or possibly the slow biodegradability of the 
small cell variants of C. burnetii [20]. A study evaluating the protective activity of PI-
LPS and PII-LPS suggests PI-LPS might be responsible for PI vaccine-induced 
protection against C. burnetii infection [5]. Both AMI, or humoral, and CMI responses 
are believed to be important for developing protective immunity against C. burnetii 
infection [21]. This was demonstrated in a study examining PI vaccinated mice. Passive 
transfer of immune sera provided significant protection against C. burnetii infection. 
Similarly, bacterial loads were significantly reduced in mice receiving immune 
splenocyte and T cells [5]. Future Q fever vaccine approaches should focus on boosting 
both the AMI and CMI responses.  
 Between 2007 and 2011 in the Netherlands, a Q fever outbreak involved more 
than 3500 human cases, leading to 24 deaths [22]. Most cases occurred in the spring and 
early summer and were concentrated in the south of the country. A vaccination program 
was put into effect when dairy goats were identified as the source of the human Q fever 
cases, and farmers had to vaccinate their animals whether infected or not [23]. More 
drastic veterinary measures were taken when vaccination did not successfully contain the 
 6 
 
outbreak. Between December 2009 and June 2010, over 50,000 animals were culled on 
infected farms [24]. This outbreak is a reminder that Q fever remains a threat worthy of 
continued research to improve our understanding and overcome challenges with 
diagnosis and treatment. 
 Its highly infectious nature, aerosol transmission, and ability to survive in 
adverse environments make C. burnetii a potential biological weapon and have led to its 
classification by the Centers for Disease Control and Prevention (CDC) as a Category B 
select agent [25]. A biological warfare attack with Q fever would cause a disease similar 
to that occurring naturally. Though the disease is rarely fatal, it would put a significant 
strain on our healthcare system. If used in a cocktail with a Category A agent, Q fever 
would certainly complicate the response to an outbreak. In addition to its relevance as a 
potential bioterrorism agent, C. burnetii also presents a risk for natural infection in 
deployed military personnel. There have been greater than 30 cases reported among US 
service members deployed to Iraq and Afghanistan, and the disease continues to be a 
global threat to both humans and livestock [26].   
Virulence Model  
 C. burnetii has a biphasic lifecycle and is able to transition between two 
developmental stages that contribute to its environmental stability. Small cell variants 
(SCV) are typically rod shaped, 0.2-0.5 μm long, infectious particles that are 
metabolically inactive [27]. SCVs exist in the extracellular environment and are resistant 
to harsh environmental conditions [1]. Once inside the host cell, the SCV transitions to a 
large cell variant (LCV), which is metabolically active and can exceed 1 μm in length 
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[27]. This shift from SCV to LCV occurs alongside maturation and acidification of the 
PV, without replication, and accounts for the initial lag phase in C. burnetii growth [27]. 
LCVs replicate for many days, expanding the PV. Once large numbers of LCVs 
accumulate, C. burnetii converts back to SCVs which are then released by a still 
unknown mechanism [28]. Proteins expressed between these two cell variants could 
potentially be virulence factors. A comparison of protein profiles between the two 
variants found 48 proteins that were greater than two-fold more abundant in LCVs than 
SCVs and six proteins that were at least two-fold more abundant in SCVs [25]. These 
proteins could potentially be involved in immune evasion and should be studied further. 
 Once inside the host cell, intracellular pathogens typically employ mechanisms to 
subvert phagosomal maturation. Mycobacterium tuberculosis, for example, arrests 
phagosome maturation at an early stage. Legionella pneumophila promotes fusion of the 
Legionella containing vacuole with endoplasmic reticulum-derived membranes instead 
of endolysosomal compartments, and Listeria monocytogenes escapes the phagosome 
and replicates in the cytoplasm [29]. C. burnetii, however, actively directs the 
maturation of a phagolysosome-like compartment known as the Coxiella-containing 
vacuole (CCV) [30]. This parasitophorous vacuole (PV) has lysosomal characteristics, 
containing LAMP-1 and cathepsin D [31]. C. burnetii actively modifies this PV, but the 
specific proteins involved are still being identified. Recently, T4SS effectors were shown 
to be secreted through the membrane of the PV, a requirement for C. burnetii maturation 
and replication [32]. Additional work is needed to determine potential virulence factors 
involved in PV development and C. burnetii replication inside this harsh environment. 
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Virulence Determinants  
 Bacterial virulence factors are expressed proteins or toxins that enable the 
organism to enter, replicate, and persist in a host. They are typically defined by 
comparing mutated strains to wild type and looking for avirluent phenotypes. This 
hypothesis is based on Koch’s postulates, which establish criteria to determine if a 
specific microbe causes a disease [33]. Currently, only two virulence factors have been 
confirmed for C. burnetii: LPS and a type IVb secretion system [34,35]. The 
identification of additional C. burnetii virulence factors using recently developed genetic 
techniques will be instrumental in finding targets for new therapies. Several putative C. 
burnetii virulence factors will be discussed here. 
 Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-
negative bacteria and is exposed on the cell surface of unencapsulated bacteria. 
Lipopolysaccharides are made up of three structural components: lipid A, a hydrophobic 
lipid section responsible for its endotoxic properties; a hydrophilic inner and outer core 
polysaccharide chains; and a species-specific O-antigen oligosaccharide side chain [36]. 
LPS phase variation is a shift from virulent phase I cells containing smooth, full-length 
LPS I to avirulent, rough phase II cells with a modified LPS II that lacks the O-antigen. 
This occurs after passage of Coxiella in a non-immunologically competent host. In 
contrast to other bacterial pathogens, phase variation in C. burnetii phase II is 
irreversible due to the large chromosomal deletion associated with the rough phenotype 
[37]. The deletion includes 21 ORFs (CBU_0679 to CBU_0698); however, there are 
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likely additional mutations since NMII has a shorter deletion but produces a more 
truncated LPS than NMC [38].  
 NMI LPS is hypothesized to shield potential TLR ligands, such as lipoproteins, 
from recognition. NMI bacteria can persist in DCs without activating them in vitro. 
Infection of DCs with the avirulent NMII strain, however, induces a robust immune 
response that efficiently clears the bacteria. [34]. This is interesting given the primary 
function of a dendritic cell (DC) is to alert the immune system, not clear invading 
pathogens. 
 Adherence is the first major interaction between an intracellular pathogen and its 
host and is a prerequisite for bacterial pathogenesis. Adhesins mediate adherence to the 
host cell by exploiting and binding to cell surface receptors typically used for normal 
cell processes. Integrins are a group of eukaryotic cell surface receptors that have been 
shown to be used by a number of pathogens for adherence [39]. While internalization of 
C. burnetii by the host cell requires attachment, the specifics of this interaction remain to 
be determined. The current understanding is that virulent C. burnetii bind monocytes and 
macrophages, their primary target cells, using leukocyte response integrin (αvβ3 integrin) 
as the dominant receptor and CR3 (αMβ2 integrin) as a secondary receptor for NMII [40]. 
The same study showed avirulent phase II C. burnetii are more efficiently phagocytosed 
than virulent organisms. However, this could result from a more hydrophobic membrane 
on phase II organisms lacking O-antigen. The effects of these receptors on virulence and 
the adhesion for αvβ3 are yet to be determined [41].  
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 A number of different cellular responses are triggered when C. burnetii binds 
host cells, but their involvement in the establishment and/or clearance of an infection is 
unknown. C. burnetii induces macrophages to produce TNF-α and IL-1α; however, a 
different response is seen in phase I and phase II organisms. Phase I induces greater 
TNF-α production early in infection, while secretion of TNF-α occurs later with phase II 
[42]. Also, TNF-α production is specific to phase I in dendritic cells [34] , as is IL-1α 
production in macrophages [42]. Phase I C. burnetii induce actin cytoskeleton 
reorganization and membrane ruffling when bound to host cells, a response not seen 
with phase II bacteria. This is intriguing because activation of the protein tyrosine kinase 
(PTK) inhibitors that causes membrane ruffling negatively regulates bacterial 
phagocytosis [43]. Further studies are necessary to understand exactly how the 
differences in phase I and phase II C. burnetii contribute to their distinct pathogenesis. 
 Toll-Like Receptors (TLRs) are an important innate host defense against 
microbial infection. TLRs recognize structural motifs known as pathogen-associated 
molecular patterns (PAMPs), expressed by pathogens, or danger-associated molecular 
patterns (DAMPs), released by necrotic or dying cells [44]. Of the ten human and twelve 
murine TLRs characterized, two have been shown to be activated by C. burnetii PAMPs: 
TLR 2, which typically recognizes Gram-positive bacteria, and TLR 4, which is 
predominantly activated by LPS [34,45,46]. Unfortunately, the findings of these studies 
are not in agreement. Results from one study, for example, suggest that interaction of 
phase I C. burnetii interacting with TLR 4 induces uptake [46], although it was shown 
that C. burnetii LPS acts as a TLR 4 antagonist [45]. How C. burnetii interfaces with the 
 11 
 
immune system is important to understand the dynamics of infection, and additional 
studies should be conducted to better characterize the interactions that occur between C. 
burnetii and host cell receptors. 
 The second major virulence factor that has been identified for C. burnetii is the 
Type IVb Secretion System (T4BSS). It is essential for the formation of the spacious 
parasitophorous vacuole (PV) required for intracellular replication of C. burnetii. This 
T4BSS is conserved with the Dot/Icm secretion system of Legionella pneumophila, 
encoding 23 of the 26 Dot/Icm homologs [47]. This system will be discussed in detail in 
the following section. 
 There is some evidence that the Coxiella T4BSS has a role in subverting the host 
autophagic pathway. Autophagy is a pathway whereby cytoplasmic components are 
sequestered within a double-membraned compartment (the autophagosome) and 
degraded upon lysosomal fusion. Generally, autophagy is employed to maintain cellular 
homeostasis in eukaryotic cells; however, it also assists in the eradication of invading 
pathogens. Many intracellular bacterial pathogens, including C. burnetii, subvert or 
modulate the autophagic pathway to maintain a replicative niche [48]. While other 
intracellular pathogens lyse and escape from the phagosome or modify the phagosomal 
compartment, C. burnetii is the only bacterial pathogen known to actually survive and 
replicate in the acidic, degradative PV [49].  
 One study hypothesizes that C. burnetii exploits the autophagic pathway to delay 
fusion with lysosomes, allowing the organism to efficiently replicate inside the host cell 
[50]. Proteins implicated in this process include host Beclin 1 and Bcl-2 [51] , and the C. 
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burnetii T4BSS substrates AnkG and Cig2 [52,53]. Interaction between the autophagic 
protein Beclin 1 and the anti-apoptotic mitochondrial protein Bcl-2 induces anti-
apoptotic activity. This suggests a link between C. burnetii’s interaction with 
autophagosomes and its anti-apoptotic activity [51] (Figure 1). 
 
 
 
Figure 1: Modulation of the autophagy and apoptosis pathways by C. burnetii. 
(modified from Vazquez and Colombo [51]). Once Cb is phagocytosed into the host cell, 
it uses a T4BSS to secrete proteins which induce the autophagy pathway. The 
compartment containing Cb fuses with autophagosomes, acquiring autophagic key 
proteins such as LC3, Rab24 and Beclin 1, which favor the generation of the large 
replicative vacuoles in which Cb survives and multiples. Cb recruits the anti-apoptotic 
protein Bcl-2 and inhibits apoptosis to establish a persistent infection.  
 
 13 
 
 C. burnetii induces apoptosis through the release of cytochrome c. Prevention of 
apoptosis could be used by C. burnetii to cause persistent infection, while induction of 
apoptosis later on would enable the infection to spread [54]. The T4BSS effector protein 
AnkG has been described to be involved in apoptosis by its interaction with host protein 
p32 [52]. Two other very recent studies implicate the Dot/Icm T4SS and its effectors in 
autophagy subversion and the recruitment and fusion of autophagosomes during C. 
burnetii infection [53,55]. Continued studies will identify and characterize individual 
effectors involved in and specific pathogenic mechanisms directing C. burnetii 
interaction with these pathways. 
 Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are anti-
microbial agents produced by host cell phagocytes to help control infection. Therefore, 
the evasion or suppression of the toxic effects of oxidative stress is crucial to the survival 
of pathogenic bacteria. C. burnetii, when phagocytosed by human neutrophils, prevents 
ROS production by preventing assembly of NADPH oxidase on the phagosomal 
membrane [56]. C. burnetii has also been shown to secret an acid phosphatase 
(CBU_0335) that inhibits the release of reactive oxygen intermediates [57]. Expression 
of a subset of DNA repair genes was reported to be strongly upregulated in response to 
oxidative stress [58]. Interestingly, C. burnetii remains microaerophilic, though it has 
evolved complex mechanisms to evade or resist oxidative stress [59]. Further 
investigation into this intricate relationship will aid in our understanding of important 
mechanisms of immune evasion and bacterial persistence. 
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Secretion systems 
 Gram-negative bacteria employ several secretion systems to translocate proteins 
across two lipid bilayers (the inner and outer bacterial membranes) and the host cell 
membrane. Intracellular bacteria depend on these secretion systems to modulate 
interactions with the host and subvert host pathways in order to survive. Sec-dependent 
secretion is a very well-studied, general secretion pathway universal to eubacteria. Most 
of the Sec system components are found in the C. burnetii genome [60]. Other secretion 
systems predicted to be functional in C. burnetii include: a type I secretion system 
(T1SS); a type IV pilus (T4P)-related type two secretion system (T2SS); and a type IVB 
secretion system (T4BSS) called Dot/Icm (Defect in organelle trafficking/Intracellular 
multiplication) [1]. Current understanding of these secretion systems is based largely on 
homology to Legionella pneumophila. The C. burnetii genome encodes genes, such as 
tolC, enhC, and dot/icm, that are predicted to play roles in the T1S, T4P, and T4B 
systems, respectively [61].  
 The canonical Sec pathway functions to transport proteins across the bacterial 
inner membrane into the periplasm. A recent study suggests outer membrane vesicles 
(OMVs) contribute to Sec-mediated secretion by C. burnetii (Figure 2) [62]. Portions of 
the outer membrane pinch off from the cell envelope and form OMVs containing 
periplasmic components, including virulence factors, used to manipulate the 
environment. Stead et al. recorded obvious membrane blebbing and OMV production 
during C. burnetii growth. The authors hypothesize that OMVs provide a protective 
environment for secreted cargo inside the harsh parasitophorous vacuole. 
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 Very little is known about the role a T1SS may play in C. burnetii infection, but 
the presence of a tolC gene in its genome suggests the organism is competent for type I 
secretion. Proteins secreted through the T2SS are initially transported into the periplasm 
through the Sec or Tat system. While C. burnetii doesn’t have all the components 
required for T2S, it does encode genes involved in T4P assembly. The type II secretion 
apparatus in most Gram-negative bacteria is composed of 12-15 proteins. Francisella 
spp. requires fewer proteins to produce functional type 4 pili capable of secretion [63], 
most of which have homologues in C. burnetii. Mutations in the genes involved in these 
secretion systems would greatly aid in increasing our understanding of the roles they 
play in C. burnetii virulence and survival. 
 
Figure 2: Possible Sec-mediated secretion mechanisms of C. burnetii. Proteins 
transported across the inner membrane by the Sec translocase could be secreted by a 
T1SS mediated by TolC, a T4P-like T2SS mediated by 13 pil genes, or sequestration by 
OMVs [62]. 
 16 
 
 Many pathogens depend on T4SSs to transport DNA or proteins during infection 
of a host. The T4SSs are classified into two subgroups, type IVA and type IVB 
(T4BSS). A functional T4BSS was first discovered to be required for L. pneumophila 
infection by both Ralph Isberg’s and Howard Shuman’s laboratories [64]. These groups 
independently named the genes involved in this secretion system as: dot (for defect in 
organelle trafficking) or icm (for intracellular multiplication). C. burnetii encodes 
dot/icm genes closely related to those found in L. pneumophila (Figure 3), some of 
which have been successfully substituted and function for intracellular replication [65].  
  
 
Figure 3: Type IVB secretion system of C. burnetii. Coxiella encodes 24 T4BSS 
components, including those that are hypothesized to make up the core transport 
complex [1].  
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Before C. burnetii was able to be grown outside of host cells, L. pneumophila was used 
as a surrogate host to screen a large collection of candidate protein substrates for the C. 
burnetii Dot/Icm T4BSS. Over 100 proteins have been identified as Dot/Icm substrates 
from these screens [32,47,66,67].  
 While the Dot/Icm system functions similarly in C. burnetii and L. pneumophila, 
not all genes correspond directly. Four Coxiella genes: icmS, icmT, icmW, and dotB, 
restored intracellular growth, either fully or partially, when expressed in a corresponding 
L. pneumophila deletion strain. No complementation was observed, however, with four 
other C. burnetii Dot/Icm homologous genes: icmB, icmJ, icmO, and icmP [68]. Unlike 
L. pneumophila, which requires effectors to be translocated by the Dot/Icm system 
within minutes of uptake, C. burnetii has been shown to remain viable within the 
lysosome independent of a functional T4BSS [69]. It is not surprising that the effector 
proteins would function differently in the two pathogens because C. burnetii does not 
escape the phagosome as other pathogens do. Instead, the Dot/Icm system is necessary to 
make the environment of the phagolysosome permissive for C. burnetii replication [32].  
 There are still many unanswered questions regarding the structure and function 
of the secretion systems in C. burnetii. The ability to apply genetic tools, including 
transposon mutant libraries, will undoubtedly increase our understanding of the 
pathogenic process and lead to the development of more efficient therapies and vaccines.  
Animal Model of Disease 
 Animal models commonly used in the study of Q fever include mice, guinea 
pigs, nonhuman primates, and livestock. Nonhuman primate models of Q fever are 
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essential for evaluating vaccine candidates. Rhesus and cynomolgus macaques have 
been used to assess C. burnetii infection since the 1970s [70]. These primates are an 
excellent model, showing strong similarity to acute disease in humans, including 
pulmonary radiologic changes, bacteremia, antibody response, and clinical symptoms 
[71]. However, non-human primate models are expensive, cannot be used in large 
numbers, and ethically cannot be justified during all stages of the research process. 
Because of this, small animal models of C. burnetii infection are also quite necessary. 
 The guinea pig model of clinical disease is more relevant for testing vaccines or 
antibiotic regimens than the mouse model. With this model, fever is the primary 
indicator of disease, which closely mimics human acute Q fever [70]. The guinea pig 
aerosol challenge model requires a low dose of C. burnetii organisms for the animals to 
display relevant clinical and pathological evidence of the disease, making this the small 
animal model of choice for acute Q fever [72]. Guinea pigs have also been used to model 
Q fever endocarditis by damaging the animals’ heart valves using various methods, such 
as electrocoagulation, prior to exposure with C. burnetii [73].  
 Mice are the most commonly used animal model of Q fever because of the many 
relevant genetic and immunologic tools available. For example, overexpressing IL-10 in 
transgenic mice elicits an antibody-mediated (Th2) immune response, which can be used 
to model chronic Q fever. This model allows for disease pathology to be studied [74]. 
BALB/c mice are widely used in C. burnetii research, including studies to test proteins 
for protective immunity against challenge with NMI [75]. Though A/J mice are more 
susceptible to C. burnetii infection than other inbred mouse strains [76], they are not as 
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widely used as the immunocompetent BALB/c or the immunocompromised SCID mice 
(lacking functional B and T cells). Mice do not present with many clinical signs of 
illness, so splenomegaly is primarily used for disease determination [77]. 
 In an effort to more closely mimic natural infection and determine the 
mechanism of pulmonary immunity against C. burnetii infection, studies are conducted 
using aerosol challenge. Although this is a more natural route of infection, it is difficult 
to precisely determine the number of organisms the animals receive. One study infected 
BALB/c and SCID mice with 10
8
 organisms of either the NMI or Q212 strain (human 
chronic endocarditis isolate, G). Infection developed in both immunocompetent and 
immunocompromised mice. [78]. BALB/c and SCID mice were also used to study 
innate response in lung neutrophils and macrophages after nose-only aerosol challenge 
with 10
9
 bacteria (mice received approximately 10
7
 bacteria). This was determined to be 
a working infection model resulting in splenomegaly and increased genomic copy 
number in the spleen and lungs [79]. An alternative to aerosol challenge is intratracheal 
instillation, a technique we have successfully employed in our laboratory. This is more 
effective than inhalation and results in an exact amount of inoculum delivered deep into 
the lung [80]. 
 There are several animal models of virulent phase I C. burnetii infection 
available, including guinea pig, mouse and primate models; however, SCID mice are the 
only animal model that allows high replication of C. burnetii NMII infection [81,82]. 
Acquired immunity is essential for the host to clear infection by PII C. burnetii. T cells 
specifically are necessary for bacterial clearance, while cytokines such as IFN-γ and 
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TNF-α are important for infection control [15]. Given that most of the recent advances 
with generating and complementing mutants are conducted with the avirulent NMII 
strain, a reliable in vivo model of infection is needed to characterize the phenotypes 
associated with these mutations.  
 Recently, a study of immunocompromised A/J mice was used to evaluate a new 
treatment to potentially replace doxycycline. A head-only aerosol challenge of A/J mice 
with was conducted with approximately 6x10
9
 GE/mL of avirulent NMII. The mice 
received approximately 5x10
6
 bacteria. Liposome-encapsulated ciprofloxacin delivered 
by the intranasal route was found to improve efficacy and was more efficient than 
treatment with doxycycline [83]. In the last few months, an insect model of C. burnetii 
infection was developed that is susceptible to C. burnetii NMII. This model was used to 
characterize T4BSS mutants in an in vivo system. This is the first non-mammalian in 
vivo model of C. burnetii infection, potentially suitable for rapidly characterizing mutant 
phenotypes and screening of novel antimicrobials [84]. 
Shortfalls and Recent Advances 
Axenic Growth  
 Until a recent breakthrough in understanding the organism’s metabolic pathway, 
attempts to grow C. burnetii outside of the host cell were unsuccessful. The bacterium 
had little to no metabolic activity in neutral pH buffers, but acid activation buffers (pH 
4.5) significantly enhanced C. burnetii metabolic potential in vitro [85]. This is 
consistent with the understanding that C. burnetii replicates and grows in a lysosome-
like parasitophorous vacuole (PV) that maintains a pH of approximately 4.5-5.3 [86]. 
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Unfortunately almost three decades passed before C. burnetii was discovered to encode 
terminal oxidases associated with aerobic and microaerobic respiration. Growth was 
tested under various oxygen tensions, and it was found that the number of substrates 
oxidized by C. burnetii increases as less oxygen is available [59]. Once C. burnetii was 
defined as a microaerophile, a medium was successfully developed to supported axenic 
growth of the infectious organism. Axenic growth medium, Acidified Citrate Cysteine 
Medium (ACCM), using microaerophilic conditions, allows the bacterium to replicate 
outside of host cells and to replicate as isolated colonies on solid media [59]. Because of 
this fundamental advance, an increasing number of genetic tools have been adapted, 
including transposon (Tn) systems to generate random mutants, to C. burnetii.  
 In addition to liquid culture, C. burnetii can also be grown as colonies in ACCM-
agarose using a soft agarose overlay method [59]. C. burnetii colonies are grown in the 
top medium layer by mixing 10 ml of filter-sterilized 2x ACCM-2 with 10 ml of 1% 
(wt/vol in water) melted Ultra-Pure agarose (Invitrogen) to create a 0.5% ACCM-2 
agarose base in 100- by 20-mm petri dishes. The bacterial inoculum is mixed with 2.5 ml 
of 0.25% melted ACCM-2 agarose equilibrated to 37 °C, which was prepared by mixing 
together 1.25 ml of 2x ACCM-2 with 1.25 ml of 0.5% melted agarose. This solution is 
then poured on top of the solidified ACCM-2 agarose base. Plates are incubated for 7-10 
days as described above for ACCM-2 to allow colony development. After approximately 
7-10 days incubation, small colonies become visible by the naked eye [59] . Colonies 
can be picked from the agarose by lightly touching them with a micro-pipette tip, then 
expanded in ACCM-2 liquid culture. 
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Genetic Tools 
Transformations 
 Transforming any obligate intracellular bacterium has technical constraints 
associated with it because the pathogen relies on the host cell for replication [87]. 
Coxiella must be purified from host cells before genetic transformation. Because of its 
biphasic lifestyle, bacteria should be purified when host cells contain roughly equal 
numbers of LCVs and SCVs [88]. The first successful transformation of a stably 
maintained exogenous plasmid into C. burnetii was reported nearly twenty years 
ago[89]. This came just two years after the first obligate intracellular bacterium 
(Chlamydia trachomatis) was transformed successfully, proving electroporation could be 
used to genetically transform an obligate intracellular bacterium [90]. Integration 
occurred by homologous recombination between the plasmid autonomous replication 
sequence (ars) [91] and the C. burnetii genome. This was followed by a very lengthy 
selection and expansion process, taking 2-3 months for ampicillin-resistant C. burnetii to 
be recovered from host cells [89]. However, ampicillin-resistant organisms were 
discovered without the β-lactamase gene, indicating the long selection process allowed 
spontaneous mutation [89]. Still, this was a great advance in Coxiella genetics, 
demonstrating electroporation could be used to introduce DNA into C. burnetii. 
Transposon mutagenesis 
 Transposons (Tn) are ‘jumping genes’ that can change their position in the 
genome. These genes can be isolated and put on a plasmid for integration into target cell 
genomes [92]. A transposon that inserts into a functional gene will produce a mutation 
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that will likely disrupt gene function; therefore, transposons have been used in a wide 
variety of mutagenesis studies [92]. Mariner or mariner-like elements are a diverse 
family of transposons from insects, nematods, flatworms, and humans [93]. Lampe et al. 
purified the Himar1 transposase from the horn fly, Haematobia irritans, and discovered 
that it uses a cut-and-paste transposition pathway that inserts exclusively into a TA 
dinucleotide [93]. Recently, genetic transformation was used to successfully generate a 
defined gene mutation in C. burnetii using the mariner-based Himar1 transposon system 
[88]. In this system, transformation with Himar1 required two different suicide plasmids, 
encoding either the transposon or transposase, and containing a ColE1 origin of 
replication for rescue cloning, chloramphenicol acetyltransferase (cat
R
, for 
chloramphenicol resistance), and mCherry red fluorescent protein genes [88]. Vero cells 
were infected with C. burnetii organisms transformed with the two-plasmid Himar1 
system, which resulted in 35 unique Tn insertion sites. This is a very time intensive 
process using host cells, and clonal isolation and expansion of transformants can take 8-
12 weeks [88]. Development of ACCM growth medium and semi-solid ACCM agarose 
dramatically reduces time to expand transformants to only 16 days. Importantly, this also 
allows recovery of transformants that are not capable of growth in vitro [94]. 
 Himar1-based mutant libraries generally result in robust genome coverage due to 
high transposition frequency and low target site specificity (TA dinucleotide). Members 
of our laboratory refined the two-plasmid system described by Beare, et al. by 
establishing a stable single plasmid system, designated pKM225, replacing promoter 
regions of all critical selection markers with C. burnetii-specific promoter regions [95] 
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(Figure 4). The development of a clonal Tn mutant library will significantly enhance 
characterization of C. burnetii secretions systems and increase our understanding of 
specific mechanisms of its virulence. 
 
 
Figure 4: Map of pKM225 plasmid for single-plasmid delivery of Himar1 
transposon system. The ColE1 origin of replication, mCherry fluorescence marker, and 
chloramphenicol resistance gene (cat) are contained within the inverted repeats (IR) and 
are inserted into the genome upon transformation of the plasmid. The transposable 
element, TnC9, is outside the IRs and is therefore not inserted, which keeps the plasmid 
from ‘jumping’ out of a gene once it is inserted. 
 
 
Complementation 
 Transposon mutagenesis is a powerful tool to identify bacterial genes important 
for pathogenesis and subversion of the host immune system. To rule out the possibility 
that observed mutant phenotypes could be due to unlinked loss-of-function mutations, it 
 25 
 
is important to validate these phenotypes with complementation studies [53]. 
Chloramphenicol and kanamycin have both been established as selectable markers in C. 
burnetii [96]. This allows a Tn mutant expressing one marker to be complemented with a 
Himar1 construct expressing the other marker. Beare, et al. successfully complemented 
an icmD mutant using a Tn7-based transposon system to introduce the icmDJB operon 
into the chromosome in the glmS-CBU_1788 intergenic region [69]. They used the same 
method to complement dotB and dotA mutants a year later [97]. This complementation 
strategy permits verification of virulence factors discovered by transposon mutagenesis. 
Conclusion  
 Q fever, a zoonosis caused by the Gram-negative bacterium C. burnetii, has been 
described in nearly every country worldwide. Q fever is not only an occupational hazard 
for livestock workers, but also a potential biological weapon. The organism is extremely 
stable, efficiently aerosolized and disseminated, and can remain viable over long 
periods. This coupled with its low infectious dose has led the CDC to classify C. burnetii 
as a Category B Select Agent [98]. Though C. burnetii was first isolated nearly 80 years 
ago, its mechanisms of disease are poorly understood. This is largely due to its 
intracellular lifestyle; however, recent advances have significantly progressed Coxiella 
research in the last few years. First, there was the development of a liquid medium 
allowing growth outside of the host cell, followed by colony isolation on solid medium, 
a transposon system to generate mutant libraries, and complementation studies to verify 
phenotypes. The overall goal of these experiments was to generate transposon mutant 
libraries in C. burnetii and then use these libraries to identify genes essential for growth 
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in vitro and in vivo. We optimized methods to generate defined transposon mutants, 
resulting in mutations in nearly 20% of the predicted ORFs. Included in these mutants 
were a number of bioinformatically predicted virulence factors that we further studied in 
cellular and animal models of infection. 
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CHAPTER II  
COXIELLA BURNETII MUTANT LIBRARIES 
 
 All procedures and strains used in this work were approved by the Texas A&M 
University Office of Biosafety (IBC permit #2012080) and the Institutional Animal Care 
and Use Committee (AUP #2013-0138). 
Background 
 Members of our laboratory established a stable single plasmid transposon system, 
designated pKM225, with C. burnetii-specific promoter regions for all critical selection 
markers [95]. This system was used to develop a clonal Tn mutant library, which will 
significantly enhance characterization of C. burnetii secretions systems and increase our 
understanding of specific mechanisms of its virulence. Colony growth was used for 
selection and isolation of C. burnetii insertion mutants. C. burnetii was transformed with 
pKM225 and grown in the presence of 5 μl/ml chloramphenicol (Cm). Individual mutant 
clones were propagated on agar plates, cultivated, stored and characterized genetically 
for location of insertion by rescue cloning (Figure 5). Transposon insertions were 
homogeneously distributed throughout the chromosome and plasmid; however, we also 
encountered several “hot spots” where the transposon inserted for multiple clones. 
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Figure 5: Methods for isolation and insert characterization of each C. burnetii 
mutant. 
 
 
 
 There are roughly 120,000 TA sites evenly distributed in the C. burnetii genome 
among nearly 2100 ORFs [38]. We hypothesize a mutant library of approximately 
25,000 independent clones would saturate the genome. Most or all of the nonessential 
genes would contain insertions, and a subset of lethal gene disruptions would identify 
essential genes in the C. burnetii genome. Pooled libraries were generated by 
transforming C. burnetii with pKM225 using conditions described for the clonal library. 
Cells were recovered in 6 mL ACCM-2 for 4-5 days before being expanded to 40 mL 
and cultured for another 4 days. Pooled transformations were either analyzed 
individually or combined into a genome saturation pool (Figure 6). Estimating 500-1000 
inserts per transformation based on colony counts from plated transformations in the 
defined mutant library, 35 transformations should generate the 25,000 clones needed to 
saturate the genome. 
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Figure 6: Methods for generating pools of transposon mutants to saturate the C. 
burnetii genome. 
 
 
 
 Mutant libraries were analyzed by one of two transposon sequencing approaches: 
high-throughput insertion tracking by deep sequencing (HITS) [99] or transposon-
directed insertion-site sequencing (TraDIS) [100]. These techniques for high-throughput 
sequencing of transposon-insertion sites were developed concurrently and follow the 
same basic workflow (Figure 7): transposon mutagenesis and construction of pools of 
single insertion mutants; enrichment of transposon-insertion junctions, purification and 
PCR, and, finally, sequencing. Another method, transposon sequencing (Tn-seq) [101], 
uses enzyme digest instead of manual shearing to cut the bacterial genome while leaving 
the transposon insert intact. 
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Figure 7: Transposon insertion sequencing methods. (modified from van Opijnen and 
Camilli [83]) Two methods of transposon sequencing are illustrated. These methods are 
very similar, beginning with a pool of genomic DNA from the Tn insertion library and 
ending with sequencing of the Tn junctions. 
 
 
 
The aim of this study was to generate a large and diverse C. burnetii transposon 
mutant library near saturation for all non-essential ORFs in ACCM in order to map C. 
burnetii genes essential for growth and viability. We also expect to identify a set of basic 
structure and metabolic related genes that are required for survival and replication in 
ACCM. We expect that 200-300 ORFs are essential for C. burnetii growth in ACCM.  
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ORFs not represented by insertions in the pooled library should also be unavailable in 
the defined insertion library. Currently, only two virulence factors have been confirmed 
for C. burnetii: LPS and a type IVb secretion system [34,35]. The identification of 
additional C. burnetii virulence factors using recently developed genetic techniques will 
be instrumental in finding targets for new therapies. 
Materials and Methods 
Bacterial Strains, cell lines, and growth conditions  
 Escherichia coli strain DH5α was propagated at 37 °C in Luria-Bertani (LB) 
broth or agar, purchased from Difco (Sparks, MD). Media were autoclaved to 121 °C for 
30 minutes and supplemented with the appropriate filter sterilized antibiotic(s) at the 
final concentrations listed: chloramphenicol (Cm) (34 μg/ml) or kanamycin (Kan) (50 
μg/ml). Broth cultures were usually grown overnight (O.N.) in 5 ml of LB and shaken at 
200 rpm. Selected strains were stored at -80 °C after resuspending 5 ml of O.N. culture 
in 1 ml of autoclaved glycerol (10% v/v) in LB without antibiotics.  
 The laboratory derived C. burnetii Nine Mile phase II (NMII), strain RSA 439 
clone 4, was cultivated in T-75 cell culture flasks or 0.2-μm-pore-size-filter-capped 125-
ml Erlenmeyer flasks containing 75 ml of medium or T-25 flasks containing 20 ml of 
medium grown in filter sterilized liquid ACCM-2 or ACCM-agarose. Cultures were 
grown for approximately 7 days at 37 °C in a 2.5% O2 and 5% CO2 environment. 
Oxygen was displaced by nitrogen gas. Where required, Cm was used at 5 µg/ml.  
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Transposon mutagenesis of C. burnetii NMII 
 We used pKM225, a Himar1-based single plasmid transposon system, to 
inactivate a large fraction of the genome. C. burnetii, axenically cultured to stationary 
phase in ACCM-2, was washed twice and resuspended in water to an approximate 
concentration of 1 X 10
9. 1µg of pKM225 plasmid DNA was added to 50 μl bacteria and 
electroporated under the following conditions: 2.5kV, 200Ω, 25μF. Following 
electroporation, the bacteria were recovered O.N.  in 6 mL ACCM-2. The following day, 
5 μg/mL Cm was added to bacterial cultures. Bacteria was then grown for an additional 
2-3 days and plated on ACCM-agarose plates containing chloramphenicol.  
Colony Formation 
 C. burnetii colonies were established using a modified soft agarose overlay 
method in which bacteria are grown in the top medium layer. A 0.5% ACCM-2 agarose 
base in 100- by 20-mm petri dishes was created by mixing 10 ml of filter-sterilized 2x 
ACCM-2 with 10 ml of 1% (wt/vol in water) melted Ultra-Pure agarose (Invitrogen). 
The bacterial inoculum was mixed with 2.5 ml of 0.25% melted ACCM-2 agarose 
equilibrated to 37 °C, which was prepared by mixing together 1.25 ml of 2x ACCM-2 
with 1.25 ml of 0.5% melted agarose. This solution was poured on top of the solidified 
ACCM-2 agarose base. Plates were refrigerated (4 °C) for 30 min to aid solidification of 
the top agarose and then placed in a laminar airflow biosafety cabinet with lids ajar for 
20 min to remove condensation. Plates were incubated for 7-10 days as described above 
for ACCM-2 to allow colony development. After approximately 7-10 days incubation, 
small colonies become visible by the naked eye. Single colonies were isolated and 
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resuspended in 500ul ACCM-2 in 48 well plates. Following an additional 4-5 days, 
cultures were expanded to 20mL for another 7 days. We then pelleted the cultures and 
isolated DNA for rescue cloning. 
DNA isolation and rescue cloning 
 After approximately 7 days, the turbid bacterial culture was transferred to a 40 
ml oakridge tube and spun at 15k rpm for 20 minutes at 4 °C. The pellet was 
resuspended and transferred to a 1.5 ml eppendorph microcentrifuge tube and spun again 
at 15k rpm for 20 minutes at 4 °C. Genomic DNA was isolated for rescue cloning of 
Himar1-containing fragments following the manufacturer’s directions (GenElute 
Bacterial Genomic DNA Kit, Sigma-Aldrich, St. Louis, MO), eluted in 50 μl of elution 
solution. Purified DNA was digested with the HindIII high fidelity (HF) enzyme (NEB) 
by adding 2 μl enzyme and 5.2 μl cutsmart buffer and incubating the reaction at 37 °C 
for 2h. The enzyme was then heat inactivated at 80 °C for 20 minutes. Ligation reactions 
were carried out in a 16 °C water bath O.N. by adding 5.7 μl of 10X T4 DNA ligase 
buffer and 2 μl of T4 DNA ligase to the reaction tube.  
Transformation 
 To prepare E. coli chemically competent cells, a single colony was inoculated in 
5 ml of LB and incubated O.N. at 37 °C while shaking at 200 rpm. Two ml of the O.N. 
culture was used to inoculate 200 ml of LB medium in a 500 ml flask. Once the OD600 
reached 0.6-0.8, the culture was chilled on ice for 15 minutes. The cells were centrifuged 
at 3300g for 10 minutes at 4 °C. The pellet was resuspended by gently swirling 30-40 ml 
of cold 0.1 M CaCl2 and incubated on ice for 30 minutes. The cells were centrifuged 
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again at 3300g for 10 minutes at 4 °C and gently resuspended in 2 ml of cold 0.1 M 
CaCl2 plus glycerol (15% w/v). Five hundred μl of competent cells were transferred to 
microcentrifuge tubes and frozen at -80 °C. Chemical transformation was performed by 
adding 50 μl gently thawed competent cells to the entire ligation reaction. After gentle 
mixing, the sample was incubated on ice for 30 minutes. Heat shock was performed at 
42 °C for 45 seconds and the reaction was immediately returned to ice. One hundred μl 
of SOC media (900 ml dH2O, 20 g bacto tryptone, 5 g bacto yeast, 2 ml 5 M NaCl, 2.5 
ml 1 M KCl, 10 ml 1 M MgCl2, 10 ml 1 M MgSO4, 20 ml of 1 M glucose) was added to 
the sample and allowed to recover at 37 °C for 1 hour prior to plating on selective media. 
Plates were incubated at 37 °C for 2 days, when pink colonies became visible. One to 
three colonies per transformation were picked and inoculated in 5 ml of LB with Cm and 
incubated O.N. at 37 °C while shaking at 200 rpm. 
Plasmid isolation 
 Plasmids were isolated from bacterial O.N. cultures by alkaline-SDS lysis 
following the manufacturer’s directions (Thermo GeneJet Plasmid Miniprep Kit). 
Plasmid concentrations and purity were determined by evaluating the OD260/280 and 
OD260/230 values determined from a NanoDrop Spectrophotometer. An OD260/280 value 
greater than 1.8 and OD260/230 greater than 2.0 indicated the sample was pure enough for 
sequencing and reliable genetic manipulation.  
Touchdown PCR 
 As an alternative to rescue cloning and transformation into E. coli, we used 
touchdown PCR to identify Tn insertions in the genome [102]. PCR reactions were 
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performed in a 50 μl mixture containing 100 pmol hybrid primer (HIB17 ), 20 pmol Tn 
specific primer (ColE1-R), 100-400 ng gDNA template, 1x PCR buffer (60 mM Tris-
SO4, 18 mM NH4SO4),  0.2 mM each dNTP, and 1.5 U of Platinum® Taq DNA 
Polymerase High Fidelity (Invitrogen). PCR consisted of two phases: phase 1 included 
an initial step of 95 °C for 5 min, followed by 25 cycles of denaturation at 95 °C for 45s, 
annealing at variable temperatures for 45 s, and extension at 72 °C for 2 min. In the first 
cycle, the annealing temperature was set to 60 °C and, at each of the 24 subsequent 
cycles, the annealing temperature was decreased by 0.5 °C per cycle down to 47.5 °C. 
Phase 2 consisted of 25 cycles of 95 °C for 45 s, 50 °C for 45 s, and 72 °C for 2 min. 
After the last PCR cycle, the samples were cooled to 4 °C, and a 6 μl aliquot of the 
amplification products was electrophoresed on a 1% agarose gel (1x TAE), stained with 
ethidium bromide, and visualized under ultraviolet (UV) light.  
Sequencing plasmids for transposon insertions 
 Plasmids or PCR products were sent to Europhins MWG Operon (Huntsville, 
AL) for sequencing in a 96 well plate with 8 μl plasmid DNA and 4 μl primer (CatF or 
ColE1-R) per well to determine genomic insertion site of Himar1 transposon. Sequences 
of primers obtained from Integrated DNA Technologies (San Diego, CA) are listed in 
Appendix C. 
Analysis of Transposon-Insertion sites 
 For mapping insertion position within the genome, the sequence reads obtained 
were aligned (BlastN) against the C. burnetii phase I (RSA 493) whole genome 
sequence [60]. For each analyzed sequence, the inverted terminal repeat (ITR) region, 
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5’-ACAGGTTGGCTGATAAGTCCCCGGTCTC-3’, which flanks the transposon, was 
localized and the location where the transposon was inserted within the genome was 
determined by identifying the start and end positions of the matching sequence with 
respect to the genome sequence.  
Generation of Pooled Libraries 
 Approximately 500 independent mutants were expected to be generated per 
transformation. In order to obtain saturation of the C. burnetii genome, 50 independent 
transformations were performed with pKM225 as described above, except 
transformations were not plated on ACCM-agarose. Instead, each transformation was 
recovered in ACCM-2 for 5-7 days then stored separately as well as pooled into a high-
density transposon mutant library. C. burnetii transposon pooled libraries were grown 
and DNA isolated as described above for individual cultures. 
Preparation of pooled libraries for sequencing: HITS 
 Analysis of the input libraries will be performed to demonstrate uniform 
distribution in chromosomes and the identification of genes essential for survival in 
ACCM using HITS. Genomic DNA from pooled C. burnetii Tn libraries was diluted to 1 
μg in 130 μl total volume in TE buffer. DNA was sheared to 300 bp on a Covaris S220 
ultrasonicator using the following settings: duty cycle = 10%, intensity = 4, 200 cycles / 
burst, time = 27 s. Size selection with AMPure XP beads (Beckman Coulter) following 
manufacturer’s instructions. (Always mix 1x beads). Next, Quick Blunting end repair 
was performed at 25 °C for 30 min. PCR purify and elute in 35 μl. A 50 μl total A-
tailing reaction was set up using 5 μl NEB buffer 2, 10 μl 250 μM dATP, and 2 μl 
 37 
 
Klenow 3’-5’ exo (5 U/ml), and incubated at 37 °C for 30 min. PCR purify and elute in 
45 μl. Adaptors were ligated by adding 1 μl Promega T4 DNA Ligase (3 U/μl), 1 μl 
Adaptor B (3’ adaptor ligates both ends, T-overhang), and 5 μl buffer, and incubating 4 
hours at 15 °C followed by 15 min at 65 °C to inactivate the enzyme. The reaction was 
bead purified twice to remove all extra adaptors and eluted in 40 μl. The first PCR 
reaction, to add the 5’ adaptor (partial) to the Tn sequence, was carried out in a 100 μl 
total volume using 10 ng DNA, Phusion HF buffer, dNTPs, Himar Primer with MID 
sequence, PCR 2.0 primer, and Phusion DNA polymerase (2 U/μl) under the following 
conditions: 98 °C for 10 s, followed by 12 cycles of 98 °C for 30 s, 58 °C for 30 s, and 
72 °C for 30 s, and a final extension of 72 °C for 10 min. Bead purify and elute in 40 μl. 
The second PCR reaction, to pre-select, add biotin and the rest of the 5’ adaptor, was 
carried out in a 200 μl total volume using 125 ng DNA, 5x Phusion HF buffer, 10 μM 
Preselect F1 primer, specific INDX primer, dNTPs, and Phusion DNA polymerase under 
the same conditions as the first PCR, except with 20 cycles instead of 12. PCR purify 
and elute in 55 μl. One to 2 μg DNA was added to DynaBeads (Dynal streptavidin-
coated beads, Invitrogen) to capture and wash the sample, followed by heat denaturation 
and DNA isolation. The final PCR, used to amplify the Tn-insertion product was 
conducted in 100 μl total volume using 5 ng DNA, 5x Phusion HF buffer, 10 μM PCR 
1.0 primer, 1 μM PCR 2.0 primer, 10 μM INDX primer, dNTPs, and Phusion taq DNA 
polymerase under the following conditions: 98 °C for 30 s, followed by 8 cycles of 98 
°C for 10 s, 58 °C for 30 s, and 72 °C for 20 s, with a final extension of 72 °C for 5 min. 
Bead purify and elute in 35 μl. The final product was then analyzed for fragment length 
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on the Bioanalyzer using the High Sensitivity DNA Assay kit following the 
manufacturer’s directions. 
Preparation of pooled libraries for sequencing: TraDIS 
 Libraries for sequencing were prepared from 2.5- 5 μg of genomic DNA 
extracted from transposon libraries. Lo-bind Eppendorf tubes were used throughout the 
protocol. DNA was fragmented using a Bioruptor sonicator for 30 min with 30 s on/off 
pulses with medium intensity. Fragmented DNA was purified using the Qiaquick PCR 
Purification kit (Qiagen) according to the manufacturer’s instructions. DNA was eluted 
in 40 μl EB buffer, followed by 40 μl pure water and eluates were pooled. 1 μl of the 
purified sample was analyzed on a BioAnalyzer (Agilent) using a DNA7500 chip. The 
mean size of the DNA fragments should be below 500 bp. Next, fragments <150-bp in 
size, which would be too small for sequencing, were eliminated from the samples using 
the GeneRead size selection kit (Qiagen) according to the manufacturer’s instructions. 
DNA was eluted in 3x 25 l EB buffer. End repair and dA-tailing of end-repaired DNA 
was performed using the NEBNext DNA library prep reagent set for Illumina 
(NewEngland Biolabs) according to the manufacturer’s instructions, with a DNA clean-
up after both steps using the Qiaquick PCR Purification kit (35 l elution volume) and 
the MinElute PCR purification kit (Qiagen; 22 l elution volume), respectively. 1 μl of 
the sample was analyzed on a BioAnalyzer in order to obtain values for the 
concentration of sample and mean fragment size. Adapter ligation was performed using 
the following adapters: Adapter-1 (5’-GATCGGAAGAGCACACGTC*T) and Adapter 
PCR-1 (5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T), where * 
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symbolizes a phosphorothioate modification, which had previously been phosphorylated 
and annealed by incubating 20 l of each oligonucleotide with 5 l 10x T4 DNA ligase 
buffer and 5 l 10U/l T4 Polynucleotide Kinase enzyme (both NewEngland Biolabs). 
Annealed adapters were ligated to the A-tailed DNA fragments by mixing 17.5 μl of the 
DNA sample plus the calculated volume of annealed adapters plus 5 μl Quick T4 DNA 
Ligase with an equal volume of 2x Quick Ligation Reaction Buffer as part of the 
NEBNext DNA library prep reagent set. DNA was purified using the Qiaquick PCR 
Purification kit and eluted in 35 l PE buffer. PCR enrichment for transposon-containing 
fragments was carried out on small amounts of the ligated material as parallel PCRs in 
order to minimize amplification bias. Eight PCR reactions in volumes of 50 l were set-
up per sample consisting of: 41.9 l nuclease-free water, 5 l 10x PCR buffer with 
MgCl2, 1 l 10 mM dNTP mix, 0.3 l 100 M transposon-specific PCR-3 primer, 0.3 l 
100 M barcoded multiplexing primer (different MPX primer for each library), 1 l 
adapter-ligated DNA fragments as template, and 0.5 l JumpStart Taq DNA polymerase 
(Sigma Aldrich). The thermal cycling conditions consisted of 10 min initial denaturation 
at 94°C, followed by 20 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 30 
s, and extension at 72°C for 60 s, followed by a final extension step at 72°C for 10 min. 
PCR products were pooled and precipitated overnight at -20°C using sodium 
acetate/ethanol. DNA pellets were resuspended in 75 μl of buffer EB. 
1 μl of the sample was analysed on a BioAnalyzer in order to obtain values for the 
concentration of sample and mean fragment size. The yield of transposon-specific and 
total PCR products was also determined by qPCR. The concentration of total and Tn-
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specific PCR products in each sample was determined from the standard curve and was 
corrected for the differences in fragments size between the samples (determined using 
the BioAnalyser) and the standards (=452 bp each). The aim was to obtain samples with 
>50% Tn-specific PCR products. PCR products were size selected by dry-loading the 
samples onto a 2% agarose gel in 1x TBE buffer and electrophoresis at 60V for 90 
minutes. For sequencing, each library was diluted to 2mM and libraries were pooled 
using equal volumes.  
Preparation of pooled libraries for sequencing: Tn-seq 
 Genomic DNA from pooled C. burnetii Tn libraries was diluted to 1 μg in 130 μl 
total volume in TE buffer. Purified DNA was digested to approximately 300 bp with the 
Sau3A1 restriction enzyme (NEB) by adding 2 μl enzyme, 5.5 μl NEB buffer 1, and 5.5 
μl BSA  and incubating the reaction at 37 °C for 2h. The enzyme was then heat 
inactivated at 65 °C for 20 min. 
Sequencing of pooled libraries 
 The resulting DNAs prepared by one of the three methods described above will 
be cluster amplified and sequenced on a HiSeq2500 sequencer (Illumina) as 100 bp 
single read runs. The Illumina sequencing reads that contain the Himar1 inverted 
terminal repeats (ITRs) and the adjacent TA insertion site will be identified and aligned 
to the C. burnetii RSA493 genome sequence. The complexity of the input library will be 
determined and the number of interrupted ORFs will be analyzed after bioinformatics 
assembly. Insertions in genes that are significantly under-represented or missing in the 
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population of mutants will be considered as putative genes that are required for growth 
or survival in ACCM. 
Results  
Defined Transposon Mutant Library 
 A library of Coxiella burnetii mutants was generated by transposon mutagenesis. 
The plasmid pKM225 encoding a Himar1 transposase was used to introduce a 
transposon encoding a mCherry fluorescent protein and chloramphenicol resistance 
randomly onto the genome of the C. burnetii NMII strain RSA439. The C. burnetii 
mutants generated were isolated on ACCM-agarose plates in the presence of 
chloramphenicol and further amplified in liquid ACCM-2 supplemented with 
chloramphenicol for an additional 12 days.  
 The mutagenesis procedure was optimized to yield the greatest number of 
mutated colonies and efficient growth procedures once colonies were isolated, and the 
rescue cloning efficiency was optimized to greater than 50%. The purified plasmids were 
sequenced using the transposon-specific primer, CatF, which recognizes a sequence in 
the 3’ region of the Chloramphenicol Acetyltransferase (CAT) gene. The sequences 
were aligned on the C. burnetii RSA493 annotated genome using automated sequence 
analysis software. This analysis confirmed that isolated clones had single transposon 
insertions and were distributed homogeneously throughout the genome. Approximately 
3000 transposon mutants were isolated as single clones from 30 independent 
transformations. Of these, approximately 960 were successfully rescue cloned and 
sequenced to identify the transposon insertion sites (Figure 8). Overall, 800 transposon 
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insertions were found within C. burnetii annotated ORFs and 160 in intergenic regions 
of the genome (Table 1). The full, detailed list of all transposon insertions identified is 
included as a separate file. 
 
 
 
Figure 8: Sequenced transposon insertions. Transposon insertions were annotated on 
the C. burnetii RSA493 chromosome (large circle) and QpH1 cryptic plasmid (small 
circle). Peaks indicate the site of insertion of each transposon and the height of the peak 
corresponds to the frequency of mutants isolated presenting a transposon insertion in a 
given site (1 inner circle corresponds to 2 insertions). 
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Table 1: Current progress of C. burnetii defined transposon mutant library. Nearly 
1,000 transformants have been isolated and identified. Less than 10% of these are non-
clonal. Approximately 15% of the clonal mutants are intergenic, leaving approximately 
800 clonal mutants in predicted ORFs.  
 
Clonal 
Mutants 
(Total) 
Clonal 
Mutants 
(intergenic) 
Clonal 
Mutants  
(in ORFs) 
Clonal  
Mutants 
(unique ORFs) 
Clonal 
Mutants 
(duplicates) 
Non-Clonal 
Mutants 
961 160 801 390 290 85 
 
 
 Mutations occurred in 373 ORFs on the C. burnetii chromosome and 17 ORFs on 
the QpH1 plasmid. This corresponds to approximately 18.2% and 37% of the total ORFs 
present on the chromosome and plasmid, respectively. There were several areas of 
preferential transposon insertion, which could be due to a high AT content. The genes 
with the most insertions include: CBU_0804 (RND transporter protein), CBU_0950 
(hypothetical protein), CBU_1652 (icmX), CBU_1963 (hypothetical), and CBU_2059 
(T4SS substrate, cirE). We also generated approximately 60 insertions in dot/icm genes. 
A few of these genes are over 2 kb long, which would allow for more insertion sites. 
 There were a number of non-mutated regions (Table 2). Some of these gaps were 
expected since we compared our transposon insertions, which were generated in NMII, 
to the annotated NMI genome. There is a region of approximately 20 ORFs encoding for 
LPS (CBU_0679 – CBU_0698) in the NMI genome that is deleted in the NMII genome 
[38]. There was a large non-mutated region between CBU_0212 and CBU_0264, which 
encodes ribosomal proteins that are likely essential for bacterial survival in all 
conditions. We also saw six other regions of about 20 – 30 continuous ORFs each that 
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did not contain mutations. These could be due to mutations in essential genes or simply 
areas that we have not yet identified a transposon insert.  
 
 
Table 2: Non-mutated regions in defined Tn mutant library. These could be due to 
mutations in essential genes or simply areas that inserts have not yet been isolated. 
 
Non-mutated region Predicted function 
CBU_0115 – CBU_0132 Cell division proteins; ligases 
CBU_0212 – CBU_0264 Ribosomal proteins 
CBU_0599 – CBU_0622 Outer membrane protein precursors; 
acyltransferases and other enzymes 
CBU_0630 – CBU_0660 Enzymes: synthase, kinase, deaminase, 
dehydrogenase, and phosphodiesterase 
CBU_0677 – CBU_0700 LPS 
CBU_0808 – CBU_0854 Transcriptional regulators and activators, 
biosynthesis proteins, and enzymes 
CBU_1335 – CBU_1369 DNA polymerase, cell division proteins, and      
iron-sulfur cluster assembly proteins 
CBU_1417 – CBU_1453 Transcription, translation, and DNA repair proteins; 
NADH-ubiquinone oxidoreductase chain 
 
 
 
Pooled Transposon Mutant Library  
 High-throughput Insertion Tracking by Deep Sequencing (HITS) and Transposon 
Directed Insertion Site Sequencing (TraDIS) represent two methods for a high-
throughput functional analysis of every Coxiella burnetii gene. Using these methods, all 
the genes required for viability (and therefore all the targets for novel drug design) can 
be identified in a single experiment [99,100].  These methods have the potential for 
primarily random insertions of the transposon into the chromosome, that enables equal 
coverage and that every single gene is targeted in theory. However, insertion of the 
Himar1 transposon into the chromosome is not totally random but rather depends on the 
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presence of TA sites [103]. In order to test the suitability of a Himar transposon mutant 
pool for deep sequencing, the genome of C. burnetii RSA493 was searched for TA sites 
using the Artemis motif finder function [104]. A total of 124,724 TA sites were 
identified in the ~2Mbp RSA493 genome, resulting in an average distance of 16 bp 
between sites. No genes without at least one TA site were found, thereby confirming that 
Himar1 mutagenesis is suitable for transposon-insertion sequencing in the C. burnetii 
genome. 
 Initially, we set out to analyze our transposon mutant pools in order to determine 
redundancy and the number of pools needed to saturate the C. burnetii genome with 
mutations. Transformations yielding 250 independent clones would require 100 
transformations to saturate the genome, while a transformation yielding 2500 clones 
would only require 10 transformations. Based on our experience, the number of clones 
generated by each transformation is expected to average within this range. C. burnetii 
RSA439 was transformed with 1 μg of the pKM225 plasmid as described above. The 
transformations were recovered in 20 mL ACCM-2 for 5 days instead of being plated on 
ACCM-agarose. Five mL of the culture was pelleted and stored at -80 °C, while the 
remaining 15 mL was pelleted and DNA isolated for analysis by deep sequencing. We 
compared various purification kits to ensure the greatest yield and purity of genomic 
DNA from the pooled samples. These samples were delivered to our collaborators at 
Texas A&M AgriLife Genomics and Bioinformatics Service for library preparation and 
sequencing on the HiSeq 2500 System (Illumina). Samples were manually sheared on an 
ultrasonicator (Covaris) to an average of 300 bp, followed by a size selection using 
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AMPureXP beads (Beckman Coulter). End repair, A-tailing, and adapter ligation were 
performed with purification after each step. PCR was performed to add the 5’ adapter to 
the transposon sequence. Following a second PCR to preselect and add biotin, the 
remaining portion of the adapter was added. Products with Tn insertions were selected 
with streptavidin-coated DynaBeads
®
 (Life Technologies) followed by a final PCR to 
amplify the transposon junctions. Size and quantity of DNA in the samples were 
analyzed on a 2100 Bioanalyzer (Agilent Technologies) before being sequenced. 
 Two controls were included along with the transposon pooled libraries: one 
positive control, which contained 16 known mutants from our defined insertion library, 
and one negative control, which contained NMII genomic DNA without a Tn insertion. 
Unfortunately, while performing our bioinformatics analysis on the sequencing results, 
we discovered that our control pools did not work properly. A greater number of genes 
showed positive in our control pool than were added, and even our negative control 
yielded positive results. This may be due to PCR bias and the transposon specific primer 
with the 5’ adapter sequence potentially annealing to DNA lacking the transposon ITR 
sequence. PCR primers and procedures would need to be optimized to prevent false 
positives from showing in our libraries. 
 Because the group at Texas A&M AgriLife was inexperienced with these 
specific type of parameters, we partnered with a group at the University of Exeter, UK, 
who had successfully completed comparable sequencing experiments with several 
bacteria [105] and had recently received approval to work with C. burnetii. In addition to 
the control pools and two independent transformation pools, we sent a saturation pool 
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for sequencing. Through a series of 35 independent transformations, we created a library 
with near saturation of mutants in the diversity of genes that can be inactivated yet allow 
the bacterium to remain viable in ACCM. With 500 - 1000 insertions predicted per 
transformation, this saturation pool would be expected to contain a mutant library of 
approximately 25,000 independent clones. Sequencing of a genome saturation 
mutagenesis library could predict essential genes for conditional replication and identify 
potential virulence factors and targets for antimicrobial therapies. 
 DNA samples were prepared as described above. The 35 independent 
transformation pools were combined after recovery and prior to DNA isolation. A 
portion of these pools was plated on ACCM-agarose to confirm transformation 
efficiency. Our collaborators at Exeter used a manual TraDIS protocol for library 
preparations. In brief, the work-flow comprised fragmentation of 5 µg gDNA (or less, if 
not available) of each mutant library using a Bioruptor
®
 ultrasonicator (Diagenode), 
followed by a size-exclusion of fragments <150 bp using the GeneRead kit (Qiagen) and 
DNA purification and quantification. End repair, A-tailing, and adaptor ligation were 
performed using the NEBNext DNA library prep reagent kit (New England Biolabs), 
with purification after each step. PCR reactions were optimized to incorporate 5’ 
barcoded adapters for multiplexing, and PCR fragments were size selected on a 2% TBE 
agarose gel. Finally, the samples were subjected to 20-cycle parallel PCR enrichment for 
transposon-containing fragments on small amounts of the ligated material to minimize 
amplification bias. Products were pooled, ethanol precipitated, size-selected on a gel, 
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and purified before being submitted for sequencing as 100 bp single-end runs on a HiSeq 
2500 system at the Exeter Sequencing Facility.  
 Sequencing resulted in 7-10 million reads per sample. Reads were filtered for the 
transposon sequence, and then mapped back to the C. burnetii RSA493 genome. The 
number of mapped reads per gene (“hits”) was determined for each sample (Table 3). 
The control pools only contained 16 defined transposon mutants, making them very low-
complexity compared to the experimental pools containing all mutants from a single 
transformation, which potentially contain thousands of mutants. The control pools 
showed significantly more insertions than expected, suggesting non-specific noise in the 
system. After increasing the threshold number of hits required for a ‘positive’ result, 11 
of the 16 mutants were successfully identified. Another 3 mutants were potentially 
positive, while the remaining two were not identified in the control pools. The verified 
genes all had >1,000 Tn-insertions on average, which therefore might be used as a cut-
off point for true signals above the noise level. The two mutants from the control pool 
that did not show positive after sequencing were CBU_0372 and CBU_2013. Both genes 
only reached an average of 100 and 50 hits, respectively, which is well below the 
threshold level of 1,000 hits/gene. It remains to be determined if this could have been 
due to a problem during the PCR amplification. Moreover, 4 genes with above threshold 
level of Tn-insertions were identified, which should not have been targeted as no Tn-
mutant had been present in the pool. It remains to be elucidated, if the transposon-mutant 
pools could possibly have been contaminated with transposon mutants in these genes, or 
if these are true false positives. 
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Table 3: Results of TraDIS run with six samples. Control pools contained 16 defined 
mutants. Sample pools 1 and 2 were from single transformations. Saturation pool was a 
combination of 35 independent transformations. 
 
Sample 
# Total 
Reads 
# Filtered 
reads 
# Mapped 
reads 
% 
Mapped 
# hits within 
CDS 
# Genes 
with Tn 
Ctrl pool 1: 16n 7,169,834 7,106,051 4,454,211 62.7 4,454,04 271 
Ctrl pool 2: 16n 9,023,281 8,944,037 6,072,066 67.9 6,071,82 136 
Ctrl pool 3: 16n 8,823,415 8,746,375 5,947,547 68.0 5,947,336 121 
Sample pool 1 9,788,955 9,693,285 1,684,739 17.3 1,609,546 1591 
Sample pool 2 9,306,966 9,226,438 6,390,578 69.3 6,326,146 1259 
Saturation pool 8,435,688 8,359,340 2,933,113 35.0 2,731,88 180 
 
 
 When applying the 1,000 hits threshold to the three sample pools, which 
represent transposon mutant pools of unknown identity and complexity, only 7 genes 
were above threshold in the saturation pool, 6 genes were above threshold in sample 
pool 1, and 89 genes were above threshold in sample pool 2. Each of the six genes that 
were identified in sample pool 1, which correspond to CBU_0014, CBU_0021, 
CBU_0937, CBU_1719, CBU_1720, and CBU_1909, were also identified in at least one 
other sample, and two of them (CBU_1719 and CBU_1909), were present in all three 
samples. This could indicate that these genes represent a hotspot for transposon 
insertions.  
Discussion 
 Understanding host-pathogen interactions and identifying bacterial virulence 
determinants are essential for developing new therapies to be used against C. burnetii 
infection. The aim of this study was to generate both a library of defined C. burnetii 
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transposon mutants and a pooled transposon library to saturate the non-essential genes of 
the genome. Transposon insertions were distributed homogeneously throughout the 
genome, which can be visualized on the genome map. A number of potential T4SS 
substrates identified in our defined transposon mutant library were characterized by 
members of our lab [47]. There were a few gaps or regions where no mutations were 
identified. Some of these gaps were expected since we compared our transposon 
insertions, which were generated in NMII, to the annotated NMI genome. There is an 
approximate 26 kb region from the NMI genome that is deleted in the NMII genome. 
There was a large non-mutated region between CBU_0212 and CBU_0264, which 
encodes ribosomal proteins that are likely essential for bacterial survival in all 
conditions. However, we also identified six other regions of about 20 – 30 continuous 
ORFs each that did not contain mutations. These could be due to mutations in essential 
genes, or simply areas that we have not identified a transposon insert because mutations 
do not approach saturation.  
 We optimized the rescue cloning protocol to an efficiency of nearly 60%. 
Unfortunately, we failed to adapt touchdown PCR to work with our transposon 
mutagenesis system. Future studies should continue to pursue this approach, as we 
achieved approximately 15 – 20% success rate for defining clones (Table 4). New 
primers should be designed to include random, universal, and nested Himar primers 
combining different primer combinations and running multiple PCR reactions to achieve 
the greatest success [106]. Not all clones are successfully rescue cloned, but by 
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optimizing the touchdown approach, these two methods could be combined to allow for 
significantly higher throughput for defining transposon insertions. 
 
Table 4: Comparison of rescue cloning and Touchdown PCR methods for isolating 
and sequencing transposon insertions. 
 
Rescue Cloning Touchdown PCR 
Digest isolated gDNA 
PCR isolated gDNA using non-specific 
degenerate primer 
Ligate PCR clean-up 
Transform into E. coli Sequence 
Isolate plasmid  
Sequence  
60% efficiency, 
but time consuming and costly 
Currently only 15% efficiency 
 
 
 
 A near saturation mutant genome pool could prove extremely beneficial for 
identifying virulence determinants in C. burnetii, but there would still be a subset of 
genes not represented in our mutant libraries. The genes in these non-mutated regions 
will be characterized as essential to C. burnetii’s survival in growth conditions (ACCM) 
used to culture mutants. We generated 50 pools of transposon mutants from independent 
transformations with pKM225. These pools were tested for viability and transposon 
insertion. However, these pools are still undergoing testing to more accurately predict 
the number of ORF insertions in each pool. We combined 35 of these pools into one 
genome saturation pool and provided the purified DNA to our collaborators at the 
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University of Exeter. We obtained our first sequencing data from this saturation pool 
along with two individual pools and three control pools.   
 We were unable to achieve a reliable readout using either the HITS or TraDIS 
approach. As an alternative approach, the next attempts could perform transformations 
and plate them on solid medium instead of maintaining liquid culture. Colonies could 
then be picked and pooled into one library, ensuring a greater viability of clones in the 
pool. Another possible improvement could be to use enzyme digestion for DNA 
fragmentation than random shearing. This would allow for more specificity and greater 
efficiency in isolating the Tn junctions. A major problem that we encountered was with 
our positive control pools. The sequencing reads were producing some false positives as 
well as false negatives. About 75% of the clones in the pool were positively identified, 
yet with large variations in apparent copy number. Of the 16 transposon mutants, 14 
were successfully identified, but there were also false negatives. Previous studies 
utilizing these approaches did not include a positive control pool [99-101]. It could be 
that the Illumina sequencer is not designed to accurately read such a small number of 
products in a sample. The software needs a certain amount of diversity in order to 
accurately differentiate between sequences. This system discerns hundreds of thousands 
of clones but may become ‘confused’ with less than 20. Instead of using a positive 
control pool, false positive results could be addressed by repeating the sequencing as 
multiple replicates. Studies into analyzing the genome saturation pool by deep 
sequencing should continue, as the readouts will prove extremely beneficial to Coxiella 
research.   
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CHAPTER III  
DEVELOPING VIRULENCE RELATED SCREENING AND CHARACTERIZATION 
APPROACHES FOR SPECIFIC TRANSPOSON MUTANTS 
 
Background 
 The identification of additional C. burnetii virulence factors using recently 
developed genetic techniques will be instrumental in finding targets for new therapies. 
The aim of this study was to develop methods to identify a set of basic structure and 
metabolic related genes that are required for survival and replication in ACCM, in vitro, 
and in vivo. The mouse macrophage-like cell line, J774.A1, mouse fibroblast cell line, 
L929, and human epithelial cell line, HeLa, were used for in vitro studies. There are 
several animal models of virulent phase I C. burnetii infection available, including 
guinea pig, mouse and primate models; however, SCID mice are the only animal model 
to enable high replication of C. burnetii NMII [81,82]. 
 We predict many genes are required for C. burnetii survival and replication in 
cells or in animals while having no phenotype in ACCM-2, and that many of these genes 
are critical for its pathogenic process. The genes required for replication in cells likely 
include those that contribute to attachment, invasion, formation of a suitable replication 
niche, and persistence. The genes uniquely required for infecting animals may include 
those responsible for immune modulation or evasion. We intended to use the pooled 
mutant library to compare insertion mutant complexity between input and output pools 
from in vitro infected cells (J774.A1 or L929) or infected SCID mice; however, since the 
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methods for analyzing these pools are still being optimized, we have relied on the 
defined clonal mutants to evaluate phenotypes in this thesis. A high-throughput method 
for screening transposon mutants will be essential for comprehensive identification of 
virulence related genes since screening individual clones is time intensive and 
expensive, particularly in animals. 
 To test the hypothesis that a subset of genes will prove attenuated in one or more 
stages of the pathogenic process, bacterial clones containing Tn insertions were 
compared to NMII in tissue culture cells and a mouse model of infection. The growth 
rate and ability to infect and replicate was monitored. Additional studies on phenotypes 
of specific clones were prioritized using bioinformatic prediction of function for specific 
mutations. The results of these combined in vitro and in vivo screens provide a wealth of 
new data for future studies in an effort to understand the critical pathways essential for 
this pathogen.  
Materials and Methods 
Bacterial Strains, cell lines, and growth conditions 
 Escherichia coli strain DH5α was propagated at 37 °C in Luria-Bertani (LB) 
broth or agar, purchased from Difco (Sparks, MD). Media were autoclaved to 121 °C for 
30 minutes and supplemented with the appropriate filter sterilized antibiotic(s) at the 
final concentrations listed: chloramphenicol (Cm) (34 μg/ml) or kanamycin (Kan) (50 
μg/ml). Broth cultures were usually grown overnight (O.N.) in 5 ml of LB and shaken at 
200 rpm. Select strains were stored at -80 °C after resuspending 5 ml of O.N. culture in 1 
ml of autoclaved glycerol (10% v/v) in LB without antibiotics.  
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 The laboratory derived C. burnetii Nine Mile phase II (NMII), strain RSA 439 
clone 4, was cultivated in T-75 cell culture flasks or 0.2-μm-pore-size-filter-capped 125-
ml Erlenmeyer flasks containing 75 ml of medium or T-25 flasks containing 20 ml of 
medium grown in filter sterilized liquid ACCM-2 or ACCM-agarose. Cultures were 
grown for approximately 7 days at 37 °C in a 2.5% O2 and 5% CO2 environment. 
Oxygen was displaced by nitrogen gas. Where required, Cm was used at 5 µg/ml.  
 J774A.1 cells were cultured in Dulbecco’s Modified Eagle’s Media (DMEM) 
supplemented with 10% fetal bovine serum (FBS). Roswell Park Memorial Institute 
(RPMI)-1640 medium supplemented with 10% FBS was used for culturing L929 cells. 
All cell lines were maintained at 37 °C with 5% CO2. 
Real time quantitative PCR 
 Tissue and cells were lysed with 200 μl lysis buffer (1M Tris, 0.5M EDTA, 7 
mg/ml glucose, 28 mg/ml lysozyme) and 10 μl proteinase K (20 mg/ml) and incubated 
O.N. at 60 °C, followed by the addition of 21 μl 10% SDS and incubated at room 
temperature for 1 h. DNA was extracted using High Pure PCR Template Preparation Kit 
(Roche Molecular Biomedicals, Indianapolis, IN), and stored at -20 °C until use. Real 
time PCR (rtPCR) was performed using an Applied Biosystems 7500 Real time PCR 
System. The recombinant plasmid DNA, containing the IS1111 gene, was used as 
standard DNA to quantify copy numbers. 
Growth of transposon mutants in media 
 To rule out general growth defects, growth curves in ACCM-2 were conducted 
by inoculating 20ml ACCM-2 with 1.0x10
6
/ml of CB439, an intergenic mutant, or 
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specific transposon mutants. At 1d, 4d, and 7d post-inoculation, 1ml of culture was 
removed, pelleted, and resuspended in 200µl tissue lysis buffer with 10µl proteinase K 
[107]. DNA was isolated from the ACCM-2 cultures using High Pure PCR Template 
Prep Kit (Roche) per manufacturer’s instructions and purified DNA was quantified using 
qPCR with TaqMan and primers specific for IS1111 [108]. 
Growth of transposon mutants in vitro 
 Individual C. burnetii NMII defined mutants were used to infect HeLa, J774.A1, 
L929, or MH-S cells. Cells were seeded at 1.25x10
4
 cells/well (96-well plate) or 5x10
4
 
cells/well (24 well plate) and infected at a multiplicity of infection (MOI) 100 for 4h. An 
intergenic mutant or mCherry expressing C. burnetii-pKM244 was used as a positive 
control. Concentration of C. burnetii strains axenically cultured in ACCM-2 was 
determined using qPCR with IS1111gene specific primers [108]. Four hours post-
infection (HPI), cells were washed 3 times with 1X PBS to remove un attached bacteria, 
fresh media was added to each well, and cultures were incubated at 37 °C with 5% CO2. 
At 1d, 4d, and 7d, cells were scraped  and pelleted cells were resuspended in tissue lysis 
buffer with 10µl proteinase K [107]. DNA was isolated from the infected cells using 
High Pure PCR Template Prep Kit (Roche) per manufacturer’s instructions and purified 
DNA was quantified using qPCR with TaqMan and primers specific for IS1111 [108].  
High-throughput screening of transposon mutants in vitro 
 An alternative method to screen the large numbers of defined insertion clones in 
vitro is to image infected cells with a Nikon-A1 Confocal Microscope System (Nikon, 
Tokyo, Japan), fluorescence image or a Cytation3 cell imaging microplate reader 
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(BioTek, Winooski, VT) for detection of mCherry expression (594nm). J774.A1, L929, 
or MH-S cells were seeded in 48 or 96 well plates and infected with individual mutants 
in triplicate. Four HPI, cells were washed and fresh media +Cm was added. Cells were 
grown for 7d, fixed, stained, and analyzed.  Vacuole size and number per cell were used 
to determine efficiency of infection compared to wild type. 
Growth in vivo 
 SCID mice were infected with individual C. burnetii defined transposon mutants 
and monitored for bacterial dissemination and clearance. As previously shown by our 
lab, SCID mice (deficient in T and B cells) are susceptible to infection with the low 
virulence C. burnetii NMII strain [82]. Five – 6 week old SCID mice were infected by 
intraperitoneal (IP) route with 10
6
 bacteria (100 ul). As control infections, mice were 
infected with: wild type NMII strain (positive); a Himar1-containing isolate, which has 
inserted into an intergenic region and was determined not to have a growth defect in 
vitro (positive); or PBS buffer (negative). Clinical signs were observed and body weight 
measured daily. Mice were maintained for 14 days, sacrificed, and lung and spleen 
tissues obtained for DNA isolation and quantification by qPCR. Spleens were collected 
and weighed for determination of splenomegaly. Infected spleen and lung tissues were 
homogenized in 1mL ddH2O. To isolate DNA from tissues, 100 μl homogenized tissue 
was added to 900 μl urea or tissue lysis buffer (Roche) with 100 μl proteinase K. DNA 
was isolated from the infected cells using High Pure PCR Template Prep Kit (Roche) per 
manufacturer’s instructions and purified DNA was quantified using qPCR with TaqMan 
and primers specific for IS1111 [108]. 
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Statistical analysis 
 Statistical analyses were performed using a one-way analysis of variance 
(ANOVA) and Prism software (GraphPad Software, Inc., La Jolla, CA). 
Results 
Defined transposon mutant library in vitro 
 The defined transposon mutant library contains approximately 800 clones in 
nearly 400 unique ORFs including roughly 60 insertions in dot/icm genes. The T4BSS is 
a known virulence factor of C. burnetii [35], and studies have shown Tn insertions in 
icm gene loci are defective for intracellular replication [32,69]. One of the first clones 
we identified in our library was the T4SS component, icmX. We tested this icmX::Tn 
mutant in vitro to demonstrate our methods for generating and characterizing defined 
transposon mutants.  
 
 
 
Figure 9: Growth of icmX::Tn mutant in HeLa cells. A T4SS component mutant, 
icmX, was isolated using the mariner-based Himar1 transposon system. HeLa cells were 
infected at an MOI of 100 with each strain and growth was monitored at 7d. The icmX 
mutant displayed diminished growth and reduced vacuole size and bacterial load 
compared to the wild type, mCherry-expressing C. burnetii-pKM244. 
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 HeLa cells were infected at an MOI of 100 with the icmX::Tn mutant or C. 
burnetii-pKM244, and growth was monitored for 7 days. The pKM244 plasmid 
transformed into C. burnetii gives the bacteria Cm resistance and mCherry expression 
for fluorescent observation. The icmX mutant displayed diminished growth and reduced 
vacuole size and bacterial load compared to wild-type (Figure 9).  
 This demonstrated our strategy for generating transposon mutants was 
successful, and we could continue screening the library. However, it would be too 
expensive and time prohibitive to quantify 800 clones for infection using these methods. 
Until a high-throughput method was developed, we prioritized our efforts using 
bioinformatic prediction of function for specific mutations. T4SS components were 
tested and characterized by members of our lab using the defined transposon mutants 
[47]. Other members of our lab are studying potential T2SS components and the 
production of type IV pili and have used pilD::Tn and pilE::Tn mutants generated in our 
library to determine secretion phenotype. Work is also being done to characterize an 
enhA, B, and C ::Tn mutants. Enhanced entry proteins have been shown to be involved 
in entry of L. pneumophila into host cells, as mutations in the enhC gene resulted in a 
significantly reduced-entry phenotype [109]. Because of the similarity between these 
two organisms, we would predict a similar phenotype in C. burnetii. 
 As a method of screening more mutants at once, we seeded L929 fibroblasts in 
24 well plates at 10
5
 cells/ml and infected with comparatively prepared bacteria in 0.5 μl. 
This initial screen was conducted with 66 mutants. Cultures were incubated for 7 days 
before being fixed and analyzed by confocal microscopy. This resulted in 12 mutants 
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with a potential growth defect: CBU_0007, CBU_0053 (enhA), CBU_0062 (dnaJ), 
CBU_0064 (parE), CBU_0072 (ankA), CBU_0206, CBU_0571, CBU_0661, 
CBU_0910, CBU_0945, CBU_2082, and an intergenic mutant before CBU_1050. These 
12 mutants were then quantified by qPCR, and cells were infected on coverslips at MOI 
100 in triplicate. However, no growth defect was observed with these controlled 
infections. The phenotypes seen initially may be due to such a small volume of bacteria 
being added to each well.  
 This experiment was repeated using 170 hypothetical proteins in the defined 
transposon mutant library. These mutants were first grown in 100 μl ACCM in 96 well 
plates. L929 cells were seeded in 96 well plates (1.25 x 10
4
 cells / well). Cells were then 
inoculated with 2 μl mutant for 4 h. Cells were washed to remove unattached bacterium 
and then fresh medium was added and cells were incubated for 7 days. After infection, 
cells were fixed, stained, and analyzed for growth phenotypes on a confocal microscope 
or a Biotek Cytation 3 Imaging Reader (Figure 10).  
 We screened these mutants on the confocal microscope using a program to 
conduct automated analysis. Unfortunately, it was too sensitive to autofocus the wells in 
the plastic tissue culture dishes we were using. The confocal software would be better 
able to maintain autofocus on glass bottom plates. Another problem we ran into with this 
experiment was the number of tissue culture cells. By day 7, the wells were nearly 
saturated. Seeding at a lower number of cells per well or in a greater volume in 48-well 
plates would likely solve these issues.  
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 The Biotek Cytation3 Imaging Reader is a fully automated method of analyzing 
vacuole size and number, and relative fluorescence in each well to efficiently obtain 
visual as well as quantitative fluorescence readouts that can easily be compared between 
wells. The first sample shown below, CBU_0197, had an average fluorescence intensity 
of 36,000 (TexasRed), which was comparable to wild type (data not shown). The next 
sample, CBU_1071, showed a reduced growth phenotype, with an average fluorescence 
intensity of 23,000. Finally, the third sample, CBU_0041, has a no growth phenotype, 
and gave an average fluorescence intensity of only 7,000. This is in agreement with data 
previously reported for CBU_0041 [47]. 
 
 
Figure 10: Growth of transposon mutants in L929 cells. A screen of over 150 Tn 
mutants yielded growth defects in a number of samples. Cells were analyzed 7 days post 
infection using the BioTek Cytation3 Imaging Reader (inset) or by confocal microscopy. 
 
  
Defined transposon mutant library in vivo 
 After identifying mutants with reduced growth phenotypes in vitro, we assessed 
these mutants in vivo. We infected 5-6 week old SCID mice by intraperitoneal injection 
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with: NMII, an intergenic Tn mutant (positive control), a T4BSS component mutant 
(icmX), four Tn mutants predicted to be T4BSS substrates (CBU_2052, CBU_0041, 
CBU_0937, and CBU_0425), or a T4P component mutant (pilD). All of these mutants 
except the intergenic and pilD have clear cell growth phenotypes. Organs were harvested 
14 DPI and spleen weight was compared as a percentage of total body weight for each 
animal to determine splenomegaly (Figure 11). Mice infected with wt NMII or the 
intergenic Tn mutant showed severe splenomegaly. However, no splenomegaly was seen 
in mice infected with the other Tn mutants. 
 
 
 
 
Figure 11: In vivo model of infection established for NMII strain. SCID mice were 
infected with wt or killed NMII or a series of Tn mutants, including an intergenic 
mutant. At 14 DPI, splenomegaly was detected in mice infected with both wt NMII and 
the intergenic mutant. The remaining Tn mutants caused little increase in spleen size and 
were comparable to the naïve control group. ‘ns’: P > 0.05; ‘****’: P < 0.0001. 
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 After spleens were weighed, they were homogenized in 1 ml ddH2O. One 
hundred μl of the liquefied organ was used for DNA isolation and quantification of 
bacterial copy number by qPCR (Figure 12). As expected, the amount of bacteria found 
in the spleens correlated with splenomegaly. Spleens of mice infected with wt NMII or 
the intergenic Tn mutant contained levels of bacteria greater than the infected dose.  
 
 
Figure 12: Growth of transposon mutants in vivo. SCID mice were infected with 10
6
 
copies of wt NMII or Tn mutant strains. Spleens were harvested 14 DPI and analyzed for 
genome copy by qPCR. Both the wt and intergenic mutants showed high bacterial loads, 
while mutant strains with insertions in C. burnetii ORFs displayed growth reduced by 2-
4 logs, some as low as the uninfected control. ‘ns’: P > 0.05; ‘*’: P < 0.05. 
 
 
 
 We did not recover detectable levels of bacteria from spleens of mice infected 
with the icmX, CBU_2052, or CBU_0041 Tn mutants, similar to naïve animals. Growth 
of bacteria was present but reduced in spleens of mice infected with CBU_0937, 
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CBU_0425, and pilD Tn mutants. The T4SS substrates CBU_0041, CBU_0937, 
CBU_0425, and CBU_2052, were characterized by members of our lab and determined 
to be crucial for intracellular replication and CCV formation, and were therefore 
renamed cirA, cirB, cirC, and cirD (Coxiella effector for intracellular replication), 
respectively [47]. 
Discussion 
 Transposon mutagenesis is an extremely valuable tool for studying mechanisms 
used by bacterial pathogens to evade the host immune system. The previously generated 
C. burnetii defined transposon mutant library was used to map C. burnetii genes 
essential for growth and viability. To determine which transposon mutants to begin our 
analysis with, we used bioinformatic prediction of function to identify specific genes 
suspected to encode virulence factors as defined by Koch’s postulates. We identified 
nearly 60 insertions in T4SS components (dot/icm genes), another 20 in T4SS substrates 
[47], as well as insertions in genes predicted to be involved in type IV pilus assembly 
(pil genes) and entry (enh genes). These mutants - most of which have displayed growth 
defects in vitro, in vivo, or both - have been, and continue to be, extremely beneficial in 
advancing research in our lab. 
 High-throughput screens are the most effective way to globally identify and 
characterize novel bacterial virulence determinants. Using efficient screening methods to 
analyze clonal transposon mutant libraries should provide a wealth of new knowledge 
that will dramatically improve our understanding of how this pathogen interacts with its 
host. The identification of additional C. burnetii virulence factors using recently 
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developed genetic techniques will be instrumental in finding targets for new therapies. 
The aim of this study was to develop methods to screen a library of C. burnetii 
transposon mutants and identify a set of basic structure and metabolic related genes that 
are required for survival and replication. We proposed two tools for screening host cells 
infected with transposon mutants in vitro. Both methods involve infecting cells in 48- or 
96- well plates and imaging with a high sensitivity automated digital microscopy system 
to detect fluorescence levels and determine vacuole size and number.  
 The first system uses an A1 confocal microscope imaging system, which is 
currently available in our lab. The benefits of this system are the ability to take high 
resolution images with software that can automatically focus, detect fluorescence, take 
multiple images per well, and move from one well to the next. Unfortunately, the high 
sensitivity and high resolution of this machine are also a drawback. The slightest tilt in 
the tissue culture plate will prevent the microscope from focusing in the proper plane, 
precluding detection of the cells. Because this is often a problem with plastic tissue 
culture plates, the confocal system requires use of more costly, glass bottom dishes to 
function at its highest potential. Also, given the small size of C. burnetii, 0.2 – 1 μm long 
[27], the Nikon software requires each well to be imaged at a magnification of at least 40 
or 60x, requiring more images, and thus more time, per well. 
  The second system for in vitro imaging of cells infected with transposon mutants 
uses a Cytation3 cell imaging microplate reader. This is a very high throughput system 
that could potentially result in significant time savings when screening an entire 
transposon mutant library. BioTek is a microplate instrument company, and this machine 
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has been optimized to automatically and efficiently move from well to well. The 
Cytation3 also offers autofocus, auto exposure, and auto LED intensity. It also includes a 
Hit Picking protocol--with built-in plate reader, where the plate can be read first to get 
RFUs of each well and then image only those wells of interest with high enough 
fluorescence intensity values. This also cuts down on data storage amount. Another big 
advantage of the Cytation3 is the ease of use. The user interface is friendly enough for 
untrained users to capture images or read a plate without first going through lengthy 
training. 
 Each of these systems can be extremely advantageous as a high throughput 
method for analyzing infections with Tn mutants. Another option could be to combine 
the two systems, first imaging the entire plate on the Cytation3, then analyzing specific 
wells at a higher resolution using the confocal microscope. The Cytation3 could serve as 
the workhorse, even by inexperienced users, due to its speed and ease of use. This would 
save the confocal for specific imaging and experienced users, and help prevent damage 
to confocal, which is usually expensive to maintain. Any phenotype observed on one of 
these systems would then be further characterized by quantifiable infection studies to 
determine difference in uptake, growth rate, CCV formation, or other phenotypes. 
 Screening a library of defined transposon mutants with a digital imaging system 
is a valuable tool that can be used to identify growth phenotypes in vitro; however, there 
is still a need for a high-throughput method of screening these isolated mutants in vivo. 
Recently, an insect model of C. burnetii NMII infection was developed. This model was 
used to characterize T4BSS mutants in an in vivo system. This is the first non-
 67 
 
mammalian in vivo model of C. burnetii infection and is potentially suitable for rapidly 
characterizing mutant phenotypes [84].  
 Using pools of random transposon mutants is a well-established method of 
efficiently identifying genes essential for bacterial invasion and replication in the host 
[110]. A Himar1 transposon system is used to generate a pool of random mutants. This 
mutant pool is then subjected to various growth conditions or infection models and 
surviving mutants are recovered in an output pool. The insertion site of the transposon in 
each mutant in the input and output pools are identified by next-generation sequencing 
and compared to each other. Genes in which no transposon insertions are being detected 
in the output pool are considered to be essential for a defined growth or virulence 
condition. This would be an extremely useful tool for identifying genes essential for 
growth in vitro and in vivo, since nearly all genes could be analyzed in a single well or 
animal. 
 A thorough understanding of C. burnetii virulence factors is lacking. Major 
advances in Coxiella research in recent years allow for high throughput screens of large 
libraries of transposon mutants. This study establishes methods for evaluating libraries 
of defined Tn mutants and pools of Tn mutants, which will ultimately lead to the 
identification of bacterial genes involved in host/pathogen interactions.   
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
 C. burnetii is a Gram-negative bacterium that causes the zoonosis Q fever. The 
disease, which has been described in nearly every country worldwide, was first 
identified almost 80 years ago. Despite this, its virulence mechanisms are poorly 
understood [98]. The organism’s intracellular lifestyle has been a major roadblock in the 
field of Coxiella research, but recent advances have helped researchers overcome these 
hurdles and significant progress has been achieved in the past few years. These tools 
should allow identification and characterization of specific mechanisms of C. burnetii 
pathogenesis [4]. 
 The long range goal of this study was to generate transposon mutant libraries in 
C. burnetii, and then use these libraries to identify genes essential for growth in vitro and 
in vivo. The broad objective was to develop methods to identify a set of basic structure 
and metabolic related genes that are required for survival and replication. Recent 
advances in growth medium and the development of a single plasmid Himar1 transposon 
system by our lab supported the hypothesis that a large collection of specific clonal 
mutations in C. burnetii could be isolated and screened for their contribution to the 
pathogenic process in vitro and in vivo. Although we did not approach saturation of the 
genome with our defined Tn mutant library, we optimized methods to generate defined 
transposon mutants, resulting in mutations in nearly 20% of the predicted ORFs. 
Included in these mutants were a number of bioinformatically predicted virulence factors 
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that we further studied in cells and an animal model of infection. Our findings are 
consistent with previous studies that demonstrate the Dot/Icm T4BSS is essential for 
generating and replicating in a large PV [32,47,69,97].  
 We also developed methods for high throughput screening of Tn mutants in vitro 
by imaging on either a Nikon confocal microscope or a BioTek Cytation3 imaging 
system. The confocal is more sensitive and higher resolution but requires more time and 
technical proficiency. The Cytation3 does not produce high resolution images but is easy 
to operate and can analyze an entire microplate very quickly. Similar methods for 
screening C. burnetii Tn mutants have recently been reported [53,111]. 
 We generated a genome saturation transposon mutant pool by combining 
transposon mutant pools from 35 independent transformations. With each transformation 
expected to generate 500-1000 Tn insertions, this should be more than sufficient to 
saturate all of the non-essential ORFs in the C. burnetii genome. Although we were 
unable to analyze the level of genome saturation in the random transposon mutant pools 
by deep sequencing, significant steps were made to optimize this procedure. The first 
step in the library preparation protocol may need to be updated to use enzyme digestion 
instead of an ultrasonicator to shear the DNA. More specificity might also be achieved 
by redesigning the primers and using only 1 adaptor instead of 2. Finally, using needle 
aspiration on output pools to release bacterial DNA from eukaryotic host DNA would 
provide a more pure pool for sequencing. The identification of additional C. burnetii 
virulence factors using these recently developed genetic techniques will be instrumental 
in finding targets for new therapies.  
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Future directions 
 Clonal transposon mutants should continue to be generated to approach 
saturation of all non-essential ORFs in the defined Tn mutant library. In addition to 
rescue cloning, touchdown PCR should be used to identify isolated clones. New or 
additional semi-random primers may be designed and try different primer combinations 
for different clones before this procedure is successful. It may also be advantageous to 
screen every isolated clone, even before identifying the Tn insertion site. This would 
allow us to detect mutants from the library based on their interesting phenotypes and 
prioritize efforts to identify these clones first. It may be beneficial to explore the recently 
described insect model of in vivo infection as a means to efficiently screen Tn mutants.  
 In addition, pools of transposon mutant libraries are a valuable tool to efficiently 
identify genes essential for bacterial invasion and replication in the host. The procedure 
for analyzing these libraries is nearly optimized, and then we will be able to identify 
essential genes by this method as well. Genes essential for the innate immune response 
would not be expected to show a growth defect in vitro but should prove attenuated in 
the SCID mouse model. It would not be feasible to test every clonal mutant that 
replicates normally in cells, individually in a SCID mouse.  Therefore, comparing input 
and output pools by TraDIS is the most efficient means of identifying innate immune 
genes. 
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APPENDIX A 
LIST OF BACTERIAL STRAINS AND PLASMIDS USED IN THIS STUDY 
 
Strain / Isolate Description Source 
C. burnetii 
RSA439 
Phase II, Clone 4 Montana, tick, 
1935 
E. coli DH5α F ́(Φ80d(lacZ)M15), recA1, endA1, gyrA96, 
thi1, hsdR17 (rk-mk+), supE44, relA1, deoR, 
(lacZYA-argF),U169 
 
Stratagene 
pKM225 pMW1650, com1p-TnA7, groESp-mCherry, 
com1p-cat, CmR 
 
K. Mertens 
[95] 
pKM244 pJB908a, groESp-mCherry, com1p-cat, CmR, 
AmpR 
 
K. Mertens 
[95] 
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APPENDIX B 
LIST OF PRIMERS USED IN THIS STUDY 
 
Name Sequence Experiment 
catF 
5’-GTACTGCGATGAGTGGCAG-3’ Rescue 
Cloning 
ColE1R 
5’-CTTTCCTGCACTAGATCCCC-3’ Rescue 
Cloning 
HIB17 5’-CGGAATTCCGGATNGAYKSNGGNTC-3’ Touchdown 
Himar1-F1 
5’-ACGACGCTCTTCCGATCTGAATGCGGGGACTTATC 
AGCCAACC-3’ 
HITS 
Himar1-F2 
5’-ACGACGCTCTTCCGATCTCTTACCGGGGACTTATC 
AGCCAACC-3’ 
HITS 
Himar1-F3 
5’-ACGACGCTCTTCCGATCTTCGCTCGGGGACTTATC 
AGCCAACC-3’ 
HITS 
Himar1-F4 
5’-ACGACGCTCTTCCGATCTAGCGACGGGGACTTAT 
CAGCCAACC-3’ 
HITS 
INDX15 
5’-CAAGCAGAAGACGGCATACGAGATcaggtcgGTGAC 
TGGAGTTCAGACGTG*T-3’ 
HITS 
Adaptor 1 5’-GATCGGAAGAGCACACGTC*T-3’ TraDIS 
PCR 1 
adaptor 
5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T-
3’ 
TraDIS 
MPX1 
5’-CAAGCAGAAGACGGCATACGAGATATCACGGTGA 
CTGGAGTT*C-3’ 
TraDIS 
MPX2 
5’-CAAGCAGAAGACGGCATACGAGATCGATGTGTGA 
CTGGAGTT*C-3’ 
TraDIS 
MPX3 
5’-CAAGCAGAAGACGGCATACGAGATTTAGGCGTGA 
CTGGAGTT*C-3’ 
TraDIS 
MPX4 
5’-CAAGCAGAAGACGGCATACGAGATTCAGATCGTG 
ACTGGAGTT*C-3’ 
TraDIS 
MPX5 
5’-CAAGCAGAAGACGGCATACGAGATACAGTGGTGA 
CTGGAGTT*C-3’ 
TraDIS 
MPX6 
5’-CAAGCAGAAGACGGCATACGAGATACTTGAGTGA 
CTGGAGTT*C-3’ 
TraDIS 
MPX7 
5’-CAAGCAGAAGACGGCATACGAGATTAGCTTGTGA 
CTGGAGTtC-3’ 
TraDIS 
MPX8 
5’-CAAGCAGAAGACGGCATACGAGATGATCAGGTGA 
CTGGAGTtC-3’ 
TraDIS 
Himar-PCR-
3 
5’-AATGATACGGCGACCACCGAGATCTACACAGTCA 
GTTATTGGTACCCTTAAAC*G-3’ 
TraDIS 
Himar-seq2 5’-CAGACCGGGGACTTATCAGCCAACC-3’ TraDIS 
 
